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Abstract
Echocardiography is one of the most powerful diagnostic and monitoring tools available to the modern emergency/
critical care practitioner. Currently, there is a lack of specific European Association of Cardiovascular Imaging/Acute 
Cardiovascular Care Association recommendations for the use of echocardiography in acute cardiovascular care. In 
this document, we describe the practical applications of echocardiography in patients with acute cardiac conditions, 
in particular with acute chest pain, acute heart failure, suspected cardiac tamponade, complications of myocardial 
infarction, acute valvular heart disease including endocarditis, acute disease of the ascending aorta and post-intervention 
complications. Specific issues regarding echocardiography in other acute cardiovascular care scenarios are also described.
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Introduction
Echocardiography is one of the most powerful diagnostic 
and monitoring tools available to the modern emergency/
critical care practitioner, and the provision of echocardiog-
raphy is fundamental to the management of patients with 
acute cardiovascular disease. Echocardiography can pro-
vide important information throughout the whole patient 
pathway, having been shown to change therapy in 60–80% 
of patients in the pre-hospital setting, improve diagnostic 
accuracy and efficiency in the emergency room, reveal the 
aetiology of unexplained hypotension in 48% of medical 
intensive care patients and provide information additional 
to that obtained from the pulmonary artery catheter. 
Echocardiography is now included in the universal defini-
tion of acute myocardial infarction (AMI), and in interna-
tional guidelines regarding the management of cardiac 
arrest. In the critical care setting echocardiography can be 
used to measure/monitor cardiac output and to determine 
abnormalities of cardiac physiology and coronary perfu-
sion, as well as providing more standard anatomical infor-
mation related to diagnosis. Although the potential scope of 
echocardiography is evident, specific recommendations for 
its use in acute cardiac care are currently lacking from the 
European Association of Cardiovascular Imaging (EACVI) 
and the Acute Cardiovascular Care Association (ACCA). In 
this document, we describe the practical applications of 
echocardiography in patients with acute cardiovascular 
conditions, in particular with acute chest pain, acute heart 
failure, suspected cardiac tamponade, complications of MI, 
acute valvular heart disease including endocarditis, acute 
disease of the ascending aorta and post-intervention com-
plications. Specific issues regarding echocardiography in 
different acute cardiac care scenarios are also described.
Types of echocardiographic 
imaging
The numerous challenges of imaging in the acute setting 
are well-documented, and consist in a number of factors 
including patient habitus, supine/prone positioning, posi-
tive pressure ventilation, lung injury and related features 
(pneumothorax/pneumo-mediastinum), trauma (head and 
neck, thoracic) and the presence of lines/dressings and/or 
drains. Further, the echocardiographic data must be inter-
preted in the context of the acutely/critically ill patient, 
thus incorporating a number of factors that are not nor-
mally considered by the echocardiographic practitioner 
(Table 1). Additionally, there may be time critical factors 
that further challenge the echocardiographer (i.e. cardiac 
arrest).
The choice of imaging modality in the acutely/critically 
ill patient population will not only depend upon the sensi-
tivity and specificity of the modality for a given potential 
diagnosis, but will also include the risks of transportation 
and to potentially remote parts of the hospital (i.e. for com-
puted tomography (CT) or cardiac magnetic resonance 
(CMR)). For this reason, echocardiography, performed as a 
point-of-care imaging technique, is particularly important 
in acute cardiovascular care.
Transthoracic echocardiography
Transthoracic echocardiography (TTE) is generally the ini-
tial imaging modality in the assessment of acute cardiac 
conditions. It is widely available, most cardiologists are 
trained in TTE, and it is indicated in the majority of clinical 
scenarios associated with cardiac emergencies.1 An optimal 
TTE study in the acute cardiac care setting may not be 
achievable, and echocardiography in this setting frequently 
requires non-standardized echocardiographic views. If the 
study is restricted to standard imaging planes only,2 impor-
tant findings, crucial for imaging and understanding altered 
pathology and/or physiology, can be easily overlooked. 
Despite these challenges, echocardiographic examination 
in the acute cardiac care setting should be as comprehen-
sive as possible, and undertaken with a fully equipped 
echocardiographic machine.2,3 This approach must be 
clearly distinguished from point-of-care focused cardiac 
ultrasound and/or examination with pocket-sized imaging 
devices.
Transoesophageal echocardiography
Transoesophageal echocardiography (TOE) will usually 
follow a non-diagnostic transthoracic study. However, in 
the acute cardiac care setting TOE may be chosen as a first 
line imaging technique when it is anticipated that TTE 
Table 1. Considerations that may influence echocardiographic 
findings and interpretation in critically ill patients.
Positive pressure ventilation
 •  Intubation/ventilation





Effects of sedation on myocardial function
O2 and CO2 levels
Mechanical circulatory support
Extracorporeal respiratory support
Differential effects on right and left heart
Ventricular–ventricular interaction in the context of respiratory 
support
Definition of normal range in the critical care setting
Exclusion of most patients from studies/randomized controlled 
trials
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images will be non-diagnostic, and in certain clinical sce-
narios when optimal imaging of specific structures of the 
heart and/or great vessels is mandatory. Reliance on subop-
timal TTE images may lead to missing/misinterpretation of 
findings and subsequent misdiagnosis, with potentially det-
rimental consequences for the patient. Here, TOE is man-
dated, particularly in the case of acute aortic syndromes, 
acute valvular regurgitation, acute prosthetic valve dys-
function, chest trauma/aortic transection and atrial fibrilla-
tion/flutter for exclusion of thrombus.1,4 Studies should not 
be undertaken in patients who are hypoxic and/or unable to 
protect their own airways without prior intubation and ven-
tilation. In the acutely/critically ill population, care must be 
taken to exclude/correct significant coagulopathy prior to 
TOE probe insertion, if necessary intubating the oesopha-
gus using direct laryngoscopy, and considering the use of 
paediatric probes to minimize potential trauma, particularly 
in those receiving mechanical cardiac and/or respiratory 
support. During the study, the airway and haemodynamics 
should be managed by a practitioner trained in intensive/
acute cardiac care/anaesthesia, and independent from the 
TOE practitioner.
Contrast echocardiography
Contrast echocardiography with second generation contrast 
agents allows improved visualization of the endocardium,5 
which is useful in the assessment of left ventricular (LV) 
systolic function in patients with poor endocardial border 
delineation of LV pseudoaneurysms and intracardiac 
masses.6,7 In the setting of acute cardiac failure, contrast 
injection can improve the Doppler signal envelope and be 
helpful for detecting severe aortic valve stenosis in patients 
with bad quality imaging. It may also be used to facilitate 
the diagnosis of aortic dissection.8 Despite some earlier 
safety concerns regarding the use of contrast agents, recently 
published data revealed no increase in mortality in patients 
who underwent contrast-enhanced echocardiography exam-
inations, including critically ill patients.9-12 Agitated saline 
may be useful to differentiate between intracardiac and 
intrapulmonary shunting and may be used to confirm cor-
rect placement of the cannula/drain during echocardio-
graphic-guided pericardiocentesis. Details on the clinical 
use of contrast echocardiography can be found in EACVI 
recommendations.13
Lung ultrasound examination
Lung ultrasound examination can be performed with any 
commercially available two-dimensional echocardio-
graphic machine, including pocket-sized devices, and 
may be helpful in the differential diagnosis of acute dysp-
noea, especially in diagnosing/excluding pneumothorax, 
pleural effusions and in the demonstration of interstitial 
oedema.14,15
Focused cardiac ultrasound
Focused cardiac ultrasound (FoCUS) protocols16,17 have 
been proposed for the rapid detection of significant cardiac 
pathology and assessment of volume status and biventricu-
lar function, in particular in time-critical scenarios includ-
ing cardiac arrest and trauma. A number of studies have 
shown that FoCUS may facilitate decision-making infor-
mation in the acute setting.16-18 Echocardiography is now 
recommended (where appropriately trained practitioners 
are available) in the management of cardiac arrest.18 
However, FoCUS should always be used and interpreted 
thoughtfully, since this fundamentally limited approach 
may lead to missing/misinterpretation of important find-
ings unless the practitioner is aware of its (and their) 
limitations.16,19
Pocket-sized imaging devices
Pocket-sized imaging devices have been recommended as a 
tool for a fast initial screening in an emergency setting, as 
well as an extension of physical examination in the coro-
nary and intensive care unit.20 Technical characteristics and 
image quality of these new miniaturized echocardiographic 
systems are usually sufficient for the qualitative (but not 
quantitative) evaluation of ventricular and valvular func-
tion, pericardial and pleural effusion or extravascular lung 
water;20 however, they have marked limitations of which 
the practitioner must be aware, and they must not be used to 
substitute for a comprehensive echocardiography study.
Level of competence
Performing echocardiography (TTE and TOE) and inter-
preting images in patients with acute/critical cardiac condi-
tions requires a level of competence and training of the 
operator at least equivalent to the level necessary to per-
form elective studies.21 The experienced echocardiographer 
will generally use the two techniques (TTE and TOE) inter-
changeably in order to obtain the information required. The 
operator must take into account the pathophysiological sta-
tus of the patient, frequently with rapidly changing haemo-
dynamic support, and synthesize all information to provide 
the relevant guidance to the attending physician. For per-
forming TOE studies and advanced echocardiography tech-
niques, operators should fulfil advanced echocardiography 
training requirements21 and undergo specialized additional 
training in undertaking studies in the acute setting. Since 
echocardiographic examinations in patients with an acute 
cardiovascular condition are frequently requested as urgent/
emergency, it is suggested that all such studies should be 
supervised by an expert cardiologist with an advanced level 
of competence in echocardiography19,21 and experienced in 
performing and interpreting echocardiography in the acute/
critical care setting.
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Principles, practice and specific considerations related 
to the use of echocardiography in emergency settings are 
outlined elsewhere.19 Briefly, two levels of competence are 
recommended: the independent operator level and the 
expert operator level.19 It is strongly recommended that all 
cardiologists who are involved in emergency/acute cardiac 
care on a daily or regular basis complete an additional 
training programme consisting in interpreting/reporting at 
least 150 echocardiographic examinations in critical or 
life-saving scenarios, in order to further improve technical 
skills and build experience.19 An adequate case-mix is 
essential, and at least 50 of the additional cases should be 
personally performed, documented and all interpreted 
under close supervision. For non-cardiologists the require-
ments are essentially the same; additional theoretical 
learning on certain emergency cardiovascular diseases/
conditions is, however, highly recommended. Of note, it is 
strongly recommended that sonographers and fellows 
should not routinely perform echocardiography in the 
acute/critical care setting unsupervised.
Competence can be formally assessed through a certifi-
cation process. Currently, individual certification for vari-
ous echocardiographic modalities is offered by the 
EACVI.22 Both individual competence and the competence 
of the team, facilities and appropriate logistics acknowl-
edged by successful EACVI laboratory accreditation23,24 
are likely to guarantee high-standard service in all echocar-
diographic modalities and clinical settings, including echo-
cardiography in acute cardiovascular care. In encompassing 
acute/critical care echocardiography, the certification pro-
cess therefore supports the concept of echocardiography 
‘without walls’, mirroring the patient-centric approach 
which is pivotal to acute/critical care medicine.
It is recognized that FoCUS may be helpful in selected 
cases, but it should be emphasized that EACVI in general 
strongly advocates systematic training in echocardiography 
and emergency echocardiography.16,19 Specific training and 
certification is recommended for all users of FoCUS and 
pocket-sized imaging devices, with the exception of cardi-
ologists who are certified for TTE according to national 
legislation.20 This FoCUS certification should be limited to 
the clinical questions that can potentially be answered in 
such settings. The echocardiographic examination with the 
current generation of pocket-size imaging devices does not 
allow performance of, nor replacement of, a complete 
echocardiogram20 and their limitations must therefore be 
recognized.
Clinical scenarios
A number of clinical scenarios present diagnostic challenges 
to the acute cardiac care cardiologist, with patient presenta-
tion potentially ranging from the pre-hospital setting through 
the emergency department, the cardiac catheterization labo-
ratory and the cardiac intensive care unit (Table 2).
Cardiac arrest
The most extreme presentation of the critically ill cardiac 
patient is cardiac arrest. Throughout the echocardiography lit-
erature there is evidence that the technique can be used to 
diagnose/exclude some of the causes of cardiac arrest, not 
diagnosable using any other point-of-care technique (hypovol-
aemia, tamponade, pulmonary embolism, severe LV/RV dys-
function, MI and tension pneumothorax).18,25 Where 
appropriate training is undertaken, peri-resuscitation echocar-
diography does not impact upon high quality cardiopulmonary 
resuscitation (CPR), and may potentially improve diagnosis 
and alter management throughout the whole pathway of the 
acute cardiac care patient. Specific training in Advanced car-
diac life support (A(C)LS) compliance is required even with 
experienced practitioners, in order to ensure images are 
obtained and recorded only during the pulse/rhythm check. 
International evidence-based guidelines support the use of 
echocardiography in an A(C)LS-compliant manner, by appro-
priately trained practitioners in order to diagnose/exclude 
potentially reversible causes of cardiac arrest, and guide 
immediate post-resuscitation management.18 
Acute chest pain
Patients with acute chest pain represent a significant pro-
portion (20–30%) of emergency department visits, have a 
high mortality and require rapid assessment, as treatment 
may be time-critical. Of the potential differential diagno-
ses, acute coronary syndromes (ACSs) are the most likely 
important underlying cause. ACSs are frequently character-
ized by the presence of chest pain, electrocardiogram 
(ECG) changes and a characteristic change in the cardiac 
enzyme/protein profile. However, it has been shown that 
these parameters alone may detect only approximately 30% 
of acute ischaemic events as a large majority of patients 
have atypical chest pain, a normal or inconclusive ECG and 
an early normal serum troponin level. Correct and early 
identification of ACS by traditional methods is therefore 
challenging in a significant number of patients. Here, echo-
cardiography is a valuable bedside technique in the triage 
of patients with acute chest pain. Echocardiography can be 
very useful to identify acute myocardial ischaemia and 
other major causes of chest pain such as acute aortic dissec-
tion, pericardial effusion and pulmonary embolism and for 
evaluation of chest pain in patients with unresponsive/per-
sistent haemodynamic instability despite intervention. 
Further, myocardial ischaemia is frequently under-recog-
nized in the intensive care unit, where patients may be intu-
bated and ventilated and receiving sedation/analgesia as a 
part of their routine management. Here, any haemodynamic 
instability in an at-risk patient should prompt recording of 
a 12-lead ECG, with echocardiography used to facilitate 
the diagnosis. Of note, the performance of echocardiogra-
phy should never delay the initiation of treatment.
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ACSs
Rest echocardiography. In acute ischaemic chest pain, 
the primary role of rest echocardiography is to assess the 
presence and extent of regional wall motion abnormali-
ties, encountered in different types of myocardial injury 
(ischaemia, stunning, hibernation or necrosis). Echocar-
diography alone cannot distinguish between ischaemia 
and infarction; however, the absence of wall motion 
abnormalities, especially in patients with ongoing or 
prolonged chest pain (> 45 min), excludes major myo-
cardial ischaemia. Of note, normal resting echocardiog-
raphy cannot definitively rule out a transient episode of 
ischaemia, especially in patients with chest pain of short 
duration. In patients with suspected ACS, deformation 
imaging of the LV (strain and strain rate) is a potentially 
useful technique to reveal subtle wall motion abnormali-
ties (including post-systolic shortening) when stand-
ard visual assessment of wall motion fails to detect any 
abnormalities.26,27 It is important to remember that seg-
mental wall motion abnormalities are not synonymous 
with ischaemia, and can also occur in other conditions, 
such as myocarditis, right ventricular (RV) pressure/vol-
ume overload states, LV pre-excitation, Takotsubo car-
diomyopathy, left bundle branch block or in the presence 
of a paced rhythm. During the hospital stay, echocardiog-
raphy is used to assess LV function.
Contrast echocardiography. Myocardial contrast echocar-
diography is the only technique that allows immediate and 
simultaneous point-of-care assessment of LV wall motion 
and myocardial perfusion. Several studies have reported a 
high sensitivity of myocardial contrast echocardiography, 
as compared with standard echocardiography and gated 
single-photon emission CT, to detect an ACS in patients 
presenting to the emergency room with chest pain and a 
non-diagnostic ECG.28 This technique also provides accu-
rate additional prognostic information. Indeed, patients 
with normal myocardial perfusion and function at rest 
have an excellent outcome, while the presence of perfusion 
defects at rest identifies a subset of patients at high risk for 
ACS.29 However, the choice of appropriate technical set-
tings and correct interpretation of images is highly special-
ized and requires experience and technical expertise which 
is usually outside the practice of emergency department and 
intensive care physicians, as well as many cardiologists.
Stress echocardiography. Pre-discharge exercise testing 
is currently recommended in patients without recurrent 
Table 2. Echocardiographic signs indicative or suggestive of the cause of clinical admission in acute cardiovascular conditions.




 2.  LVEDD >55 mm and/or 
> 32 mm/m²
 3.  LVESD >45 mma and/or 
25 mm/m²
 4. LVEDV > 97 ml/m²
 5. LVESV > 43 ml/m²
 6. Abnormal wall motion
 7. Functional MR and/or TR
 8.  Peak tricuspid velocity > 
3 m/s
 9.  Aortic time velocity 
integral <15 cma
10.  Diastolic dysfunction 
(E/A ≥ 2 + DT < 150 ms 
indicates increased LV 
filling pressures)b
11. Ultrasound lung cometsc
1. LVEF ≥ 50%a
2. LVEDV< 97 ml/m²
3. LVESV< 43 ml/m²a
4. E/e′ ≥13b
5. Ar – A ≥ 30 ms
6. LA volume ≥ 34 ml/m²
7.  Peak tricuspid velocity 
> 3 m/s
8.  Ultrasound lung 
cometsc + signs and 
symptoms of heart 
failure
1.  Thrombus into right 
chambers
2.  Abnormal septal motion
3.  Dilatation RA, RV (end-
diastolic RV/LV diameter 
> 0.6 or area > 1.0)
4. Global RV hypokinesia
5.  McConnell sign 
hyperkinesiad
6. Mild to severe TR
7.  Pulmonary hypertension 
around 40–50 mmHg (> 
60 mmHg in the case of 
pre-existing pulmonary 
hypertension)
1.  Usually large pericardial 
effusion
2.  Swinging heart
3. RA collapse (rarely LA)
4.  Diastolic collapse of the 
anterior RV-free wall 
(rarely LV)
5.  IVC dilatation (no 
collapse with inspiration)
6.  TV flow increases and 
MV flow decreases 
during inspiration 
(reverse in expiration)
7.  Systolic and diastolic 
flows are reduced 
in systemic veins 
in expiration and 
reverse flow with atrial 
contraction is increased
aMay be profoundly affected by use of vasoactive agents.
bMay be affected by the filling status of the presence and the use of vasoactive agents.
cNot specific for heart failure, merely indicates interstitial oedema.
dSpecificity increasingly questioned.
e All echo features must be interpreted in the clinical context, and in light of the level of cardiorespiratory support. In patients who have undergone 
recent cardiac surgery these features may be absent. Features that vary with respiration are reversed with positive pressure ventilation.
LVEF: left ventricular ejection fraction; E: early mitral inflow velocity; e′: early diastolic mitral annular velocity; A: duration of the pulmonary flow 
reversal; Ar: duration of the A-wave; LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle; LVEDD: left ventricular end-diastolic 
diameter; LVESD:  left ventricular end-systolic diameter; LVEDV:  left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; 
DT: deceleration time; IVC: inferior vena cava: TV: tricuspid valve: TR: tricuspid regurgitation.
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chest pain, normal or non-diagnostic ECG findings and 
serial negative troponin measurements. Stress echocar-
diography is indicated in patients in whom exercise ECG 
testing is submaximal, not feasible or non-diagnostic. It is 
also preferred over exercise ECG when facilities are avail-
able. Both exercise and pharmacological stress echocar-
diography have been shown to be feasible and safe when 
performed in the acute setting. They provide short-term 
prognostic information comparable to SPECT in the triage 
of patients with chest pain, allowing safe early discharge,30 
with a negative predictive value of approximately 97%. 
Pharmacological stress echocardiography (dobutamine 
infusion with addition of atropine if necessary or high-dose 
dipyridamole and atropine) can be used in patients unsuit-
able for exercise testing. Dobutamine stress echocardiog-
raphy is more cost-effective31 than exercise ECG testing. 
Stress myocardial contrast echocardiography may also be 
used to determine prognosis in patients with significant car-
diac risk factors presenting with chest pain, but a negative 
12-h troponin and non-diagnostic ECG. In these patients, a 
negative stress myocardial contrast echocardiography pre-
dicts an excellent outcome.32
Myocarditis. Acute myocarditis is a potentially serious con-
dition with a widely variable presentation and clinical 
course. To date, 2D echocardiography has played a limited 
role in the diagnosis of acute myocarditis because of a lack 
of specific diagnostic features and/or the apparently normal 
examinations encountered in its less severe forms.33 Echo-
cardiographic findings in patients with acute myocarditis 
are non-specific and may consist in: LV systolic and dia-
stolic dysfunction, resting regional wall motion abnormali-
ties, exercise-induced wall motion abnormalities (usually 
due to microvascular dysfunction) and unspecific changes 
in image texture.34 The echocardiogram may also demon-
strate intracardiac thrombi, secondary mitral and/or tricus-
pid regurgitation and co-existent pericardial involvement. 
Although the presence of myocardial interstitial oedema 
leads to a thickening of the ventricular wall in acute myo-
carditis, especially in more fulminant forms,35 echocar-
diography is not able to accurately differentiate myocardial 
oedema from wall hypertrophy.
Speckle tracking imaging is a promising non-invasive 
method that might help to identify areas of intramyocar-
dial inflammation in patients with acute myocarditis and 
no visible wall motion abnormalities/LV systolic dysfunc-
tion measured by standard parameters. A reduction in 
global systolic longitudinal strain and strain rate, as 
assessed by speckle tracking analysis, correlates with 
intramyocardial inflammation in endomyocardial biopsies 
of patients with acute myocarditis.34 However, speckle 
tracking analysis is not able to differentiate inflammation 
induced systolic longitudinal strain reduction from other 
causes that lead to alteration of LV longitudinal contrac-
tion, such as subendocardial ischaemia, infiltrative 
disease, toxin-related myocardial damage and others. 
Real-time, low-mechanical-index myocardial contrast 
echocardiography is now recommended for studying 
myocardial perfusion in various settings,13 including 
myocarditis. Areas of necrosis and inflammation have 
been demonstrated to result in myocardial perfusion 
defects,36 and the presence of perfusion defects that do not 
match a known coronary distribution territory should raise 
the clinical suspicion of myocarditis in the appropriate 
clinical setting.
Recommendations for echocardiography in patients 
with acute chest pain:
Recommended:
1. Evaluation of acute chest pain in patients with 
suspected myocardial ischaemia, non-diag-
nostic ECG and cardiac necrosis biomarkers, 
and when resting echocardiogram can be per-
formed during the pain;
2. Evaluation of acute chest pain in patients with 
underlying cardiac disease (valvular, pericar-
dial or primary myocardial disease);
3. Evaluation of patients with chest pain and 
haemodynamic instability unresponsive to 
simple therapeutic measures;
4. Evaluation of chest pain in patients with sus-
pected acute aortic syndromes, myocarditis, 
pericarditis or pulmonary embolism.
Not recommended:
1. Evaluation of chest pain in patients for which 
a non-cardiac aetiology is apparent;
2. Evaluation of ongoing chest pain in patients 
with a confirmed diagnosis of myocardial 
ischaemia/infarction.
Note: TOE may be indicated when TTE studies are 
non-diagnostic
Stress-induced cardiomyopathy (Takotsubo syndrome). Takot-
subo cardiomyopathy was originally described 20 years ago 
in Japan, as a transient, stress-induced dysfunction of the 
LV apex.37 This cardiomyopathy accounts for approxi-
mately 2% of all patients admitted with a potential diagnosis 
of ACS. Patients are typically female (>90%) and peri-
menopausal, but the condition can affect all patient groups.38 
Takotsubo cardiomyopathy mimics an ACS, with patients 
presenting with chest pain and ECG changes, but with no 
angiographic evidence of ACS.39 It is characterized by 
reversible LV dysfunction with regional wall motion abnor-
malities that do not fully correspond to typical coronary 
artery perfusion territories. The typical case of Takotsubo 
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cardiomyopathy presents with LV apical akinesia (Figure 
1), making echocardiography an ideal clinical diagnostic 
tool in many of these patients. However, coronary angiogra-
phy is mandatory in suspected cases of Takotsubo cardio-
myopathy to rule out obstructive coronary artery disease. 
Takotsubo has a more heterogeneous clinical presentation 
than initially considered, with akinesia demonstrated in the 
LV mid-cavity, LV base and RV, with or without sparing of 
the other LV segments. Biventricular involvement is 
described in about one-quarter of patients,40 and involve-
ment of the mid-ventricular segments has been recently 
reported in 40% of all cases.41 LV function must completely 
recover to confirm the diagnosis of Takotsubo cardiomy-
opathy, with the recovery time ranging from several days to 
many weeks.42
Aortic dissection and other acute aortic syndromes. Dissection 
of the aorta is a life-threatening emergency condition for 
which early diagnosis and prompt management significantly 
impact upon outcomes.43,44 Visualization of an intimal flap 
within the aorta separating the true and false lumens is con-
sidered diagnostic. The false lumen can be identified by sys-
tolic compression, spontaneous echo contrast, reversed 
systolic flow, delayed or absent flow, and thrombus forma-
tion (Figure 2). Specific criteria for identifying the true 
lumen include systolic expansion and diastolic collapse of 
the lumen, the absence or low intensity of spontaneous echo 
contrast, systolic jets directed away from the lumen, and sys-
tolic anterograde flow. Identification of the originating entry 
tear and involvement of the ascending aorta are essential to 
distinguish between type A and type B aortic dissections, as 
their management strategies are strikingly different.
A normal TTE examination cannot exclude aortic dissec-
tion; however, TTE can potentially demonstrate the intimal 
flap in the aortic root and arch and identify complications 
(acute aortic regurgitation, pericardial effusion or regional 
wall motion abnormalities suggestive of involvement of a 
coronary artery). Reverberation artefacts are a major pitfall 
with echocardiography, and the imager must be experienced 
in order to avoid misdiagnosis. TOE is a more sensitive diag-
nostic procedure;45,46 however, focused/rapid transthoracic 
scanning is strongly advised before each TOE to screen for 
cardiac tamponade and LV wall motion abnormalities. 
Cardiac tamponade may be present in type A aortic dissec-
tion and in this case, when TTE demonstrates both the dis-
section and the pericardial collection, TOE is unnecessary 
and potentially dangerous, as it may provoke haemodynamic 
decompensation. Here, TOE can be performed in the operat-
ing room to document the extension of the aortic dissection.
As compared with CMR or CT, TOE cannot visualize 
the most distal parts of the ascending aorta near the proxi-
mal arch, nor the abdominal aorta. However, aortic 
Figure 1. Electrocardiogram tracing, echocardiography and ventriculography in a patient presenting with acute chest pain, 
extensive apical wall motion abnormality (arrow) and mild elevation of troponin. Takotsubo cardiomyopathy was diagnosed after 
exclusion of significant coronary artery disease by angiography.
 at Universite de Liege on November 18, 2014acc.sagepub.comDownloaded from 
8 European Heart Journal: Acute Cardiovascular Care 
dissection strictly limited to this segment of the ascending 
aorta is extremely unusual, as generally the intimal tear 
extends into the aortic arch and can be readily demonstrated 
with TOE. In patients presenting with acute dissection of 
the abdominal aorta, clinical symptoms (i.e. abdominal 
pain) will favour CT or CMR over TOE.
Other causes of acute aortic syndrome include intramu-
ral haematoma and penetrating atherosclerotic ulcers47 
(Figure 3). TTE remains of limited value and if echocardi-
ography is the only modality of diagnosis available, TOE is 
the recommended approach, provided it is appropriate for 
the patient’s clinical status. Aortic intramural haematoma is 
considered as a precursor of classic dissection (Class 2 
Aortic Dissection), originating from ruptured vasa vaso-
rum in media layers. It can progress to acute aortic dissec-
tion or regress in some patients. Echocardiographically, 
intramural haematoma is characterized by >5 mm crescen-
tic or circumferential heterogeneous thickening of the aor-
tic wall. Sometimes, an echo-free region may be observed, 
suggesting haemorrhage or liquefaction of the haematoma. 
If the diagnosis is questionable, other imaging modalities, 
such as CMR, may be necessary. A penetrating atheroscle-
rotic ulcer (Class 3-4 Aortic Dissection) most frequently 
occurs in the descending aorta. In this situation, CT and 
CMR are the diagnostic modalities of choice. Blunt chest 
trauma is discussed in Traumatic injuries of the heart and 
aorta below.
Pericarditis. Acute pericarditis is the most common disor-
der involving the pericardium. It may be the first mani-
festation of an underlying cardiac/extracardiac disease or 
an isolated disease involving the pericardium alone. In 
patients presenting with acute chest pain, pericarditis 
must be differentiated from an ACS. A small pericardial 
effusion is a frequent complication of AMI (especially in 
patients where reperfusion of the culprit coronary artery 
was not performed) and may also present during the sub-
acute phase (Dressler’s syndrome). The diagnosis pri-
marily relies upon clinical history (chest pain changing 
with inspiration and position), examination (pericardial 
friction rub; audible, however, in only one-third of 
patients), ECG (diffuse concave upwards ST segment 
elevation and PR segment depression) and TTE features. 
However, a normal study does not exclude the diagnosis, 
with pericardial effusion detectable in only 60% of 
cases.48 Pericardial thickening (>3 mm) may be present, 
Figure 2. Transoesophageal echocardiographic examination obtained in a patient with type B acute aortic dissection.
TL: true lumen; FL: false lumen; H: intense spontaneous contrast + thrombus.
Figure 3. Severe atherosclerotic disease of the descending thoracic aorta in an elderly patient. Note the increased thickness of the 
aortic walls, protrusion of the atherosclerotic plaques into the aortic lumen and the anfractuosity of its contours. The white arrow 
indicates the presence of a penetrating ulcer of the aortic wall.
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and although echocardiography is not accurate, TOE is 
superior to TTE (Figure 4). When elevated cardiac tropo-
nin is detected (up to 50% of patients presenting with 
acute pericarditis,49 the term perimyocarditis is applica-
ble. Here serum troponin elevation reflects myocardial 
involvement in the inflammatory process, and there may 
be associated regional wall motion abnormalities.
Chronic pericarditis related to longer-term inflammation 
with fibrosis and calcification can lead to pericardial con-
striction and may be a cause of severe dyspnoea. However, 
in this case dyspnoea is gradually progressive and is rarely 
the presenting complaint in the emergency department. All 
modalities of echocardiography are very helpful for the 
diagnosis of constrictive pericarditis and for differential 
diagnosis with restrictive cardiomyopathy.
Recommendations for echocardiography in patients 
with suspected pericardial disease:
Recommended:
1. Patients with suspected pericardial disease, 
including effusion, constriction or effusive-
constrictive process;
2. Pericardial friction rubs developing in acute 
myocardial infarction accompanied by symp-
toms such as persistent pain, hypotension, 
and nausea;
3. Patients with suspected bleeding in the peri-
cardial space (i.e. trauma, perforation);
4. Guidance and follow-up of pericardiocentesis.
Acute dyspnoea
Heart failure. Acute dyspnoea is a frequent condition in 
emergency rooms. Heart failure (HF) is the most common 
cardiac cause of acute dyspnoea,50 which can be related to 
either new onset HF or to worsening of pre-existing HF.51 
Patients may present with a spectrum of conditions ranging 
from acute pulmonary oedema, cardiogenic shock, isolated 
RV dysfunction or HF complicating an ACS. The work-up 
for acute dyspnoea begins with a complete and thorough his-
tory and physical examination. However, the definitive diag-
nosis of HF may be hampered by the lack of specificity or 
sensitivity of the signs and symptoms.52 Furthermore, as HF 
is not a diagnosis per se, but rather a syndrome, additional 
investigations are required to determine the underlying 
cause. Echocardiography is an essential tool for the evalua-
tion of functional and structural changes causing and/or asso-
ciated with HF. TTE should be performed shortly following 
suspicion of HF in a patient presenting with dyspnoea.18 
Rapid diagnosis of the underlying cause, and distinction 
between HF due to systolic versus isolated diastolic dysfunc-
tion, should be obtained since identification of these features 
determines immediate treatment in the acute setting.
Echocardiographic features of systolic HF (Figure 5) 
are listed in Table 1. It is important to remember that in 
critically ill patients treated with positive inotropic agents 
and/or mechanical circulatory support the ‘normal’ values 
quoted from non-critical care studies may not be valid. 
Here, every parameter must be interpreted in the clinical 
context, including the level of cardiorespiratory support. 
In patients with dyspnoea and bilateral pulmonary infil-
trates on plain chest radiography, echocardiography can be 
used to distinguish between elevated and low left atrial 
pressure using a combination of techniques (Figure 6). In 
patients with an abnormal relaxation pattern (E/A <1), and 
peak E velocity <50 cm/s, LV filling pressures are usually 
normal. With restrictive filling (E/A ≥2, mitral E decelera-
tion time <150 ms), mean LA pressure is often increased. 
The use of additional Doppler parameters is recommended 
Figure 4. Echocardiographic examination of a patient admitted for acute pericarditis. Note the increased thickness of the 
pericardial layer close to the inferolateral and anterolateral wall of the left ventricle and absence of pericardial effusion in this 
patient with acute pericarditis (arrows).
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Figure 5. Echocardiographic examination showing dilated cardiomyopathy and depressed left ventricular (LV) systolic function in a 
patient admitted for acute dyspnoea. See also video 1 in the Supplementary material online.
Figure 6. Echocardiographic examination showing preserved left ventricular (LV) systolic function in a patient admitted for acute 
dyspnoea. The diagnosis of hypertrophic cardiomyopathy was made. The spectral tissue Doppler-derived E/e′ ratio revealed an 
increased LV filling pressure confirming the diagnosis of diastolic heart failure. See also videos 2 and 3 online.
E: early mitral inflow velocity; e′: early diastolic mitral annular velocity.
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in patients with E/A ratios ≥1 to <2 to distinguish those 
with increased LV filling pressures,53 and in ventilated 
patients a combination of Doppler parameters (mitral 
inflow, Doppler myocardial imaging, pulmonary vein 
Doppler and colour Doppler M-mode flow propagation 
velocity) is recommended.54
The diagnosis of HF with normal ejection fraction 
(HFnEF), largely corresponding to diastolic HF, is more 
challenging. HFnEF accounts for more than 50% of all HF 
patients.55 It refers to patients with HF and preserved LV 
ejection fraction (Figure 7) and requires the presence of signs 
and/or symptoms of HF and a number of echocardiographic 
parameters, listed in Table 3.51 Conventional echocardio-
graphic parameters derived from the mitral inflow pattern are 
classically poorly correlated with haemodynamics in patients 
with preserved LV function.56,57 In the acute setting and 
before treatment, diastolic dysfunction in a patient present-
ing with dyspnoea implies almost exclusively an increase in 
LV filling pressures. Advanced echocardiographic evidence 
of increased LV filling pressure includes an increased ratio of 
peak E-velocity to early mitral annular velocity (e′) using 
pulsed-wave tissue Doppler imaging (E/e′ ≥13).53 An outline 
of interpretation of LV diastolic function is represented in 
Figure 8. The presence of ≥ 2 abnormal measurements 
increases the diagnostic confidence. Of note, the ratio of 
peak E-velocity to colour M-mode flow propagation velocity 
is less accurate in this setting.
Advantages and limitations of the various echo Doppler 
parameters in assessing diastolic function have been detailed 
elsewhere.53 Atrial fibrillation and sinus tachycardia are two 
frequently associated conditions in patients presenting with 
acute HF that make analysis of diastolic function more chal-
lenging. In general, when LV ejection fraction is depressed, 
mitral E deceleration time <150 ms has reasonable accuracy 
for the prediction of increased LV filling pressures.58 In both 
reduced and preserved LV ejection fraction, a ratio of E/e′ 
(lateral mitral annulus) >10–11 can still be used to predict 
high LV filling pressures when LA volume index is increased 
(≥ 34 ml/m2) or Ar – A duration is ≥ 30 ms (A: duration of the 
pulmonary flow reversal; Ar: duration of the A-wave) or the 
delta E/A ratio with Valsalva manoeuvre is > 0.5.
In both acute systolic and diastolic HF, interstitial 
oedema may be diagnosed at the bedside by the 
Figure 7. Diagnosis of heart failure with preserved left ventricular (LV) ejection fraction (EF) in a patient presenting with dyspnoea. 
Note the preserved LVEF (>50%, (a)), the left atrium (LA) dilatation (b), the restrictive pattern of the transmitral flow (c), the high 
E/e’ ratio (d) and the increase in pulmonary systolic pressure (e).
ED Vol: end-diastolic volume; E: early mitral inflow velocity; e′: early diastolic mitral annular velocity; A: duration of the pulmonary flow reversal; 
TTG: transtricuspid pressure gradient.
Table 3. Echocardiographic contraindications to 
extracorporeal support.
Absolute contraindications to 
VA ECMO/LVAD
•  Aortic dissection 
(unrepaired)
• Severe aortic regurgitation




•  Severe ventricular 
dysfunction
• Cardiac arrest
•  Severe pulmonary 
hypertension
Relative contraindications to 
VA ECMO/LVAD
• Severe aortic atheroma
•  Abdominal/thoracic aortic 





•  Significant TV 
pathology (TS/TR)
PFO/ASD: patent foramen ovale/atrial septal defect; TS/TR: Tricus-
pid stenosis/tricuspid regurgitation; VA ECMO/LVAD: veno-arterial 
extracorporal membrane oxygenation/left ventricular assist device; VV 
ECMO: venous-venous extracorporeal membrane oxygenation 
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demonstration of an abnormally high number of bilateral 
sonographic B-lines (also called ultrasound lung comets). 
B-lines originate from water-thickened interlobular septa, 
may occur very rapidly in response to an increase in pulmo-
nary venous pressure and can be detected with a cardiac 
ultrasound probe positioned over the chest14,19 (Figure 9). A 
number of recognized protocols exist for lung ultrasound in 
the identification of interstitial oedema, and physicians 
working in the acute cardiac care environment should con-
sider undertaking additional training in this field. Of note, 
lung ultrasound merely describes the presence of interstitial 
oedema, not its underlying cause.
Cardiomyopathies. The main use of echocardiography in 
acute cardiac care of patients affected by cardiomyopathies 
relates to the diagnosis and management of acute HF. All 
cardiomyopathies can lead to acute episodes of HF, either 
in the presence of a reduced ejection fraction or when the 
ejection fraction is still normal since the main determinant 
of cardiac symptoms and prognosis is represented by the 
increase in LV filling pressure.59 Here, echo Doppler exam-
ination represents the key cardiac imaging modality 
because of its unique capacity to identify the presence of 
elevated filling pressures, and the mechanism(s) of acute 
deterioration.
Ejection fraction is not particularly helpful as a measure 
of ventricular function in the critically ill patient population 
since normal values under the conditions of ventilatory 
support are not known. Beyond ejection fraction, the appli-
cation of two-dimensional speckle tracking echocardiogra-
phy (STE) offers potentially useful information in acute HF 
patients with underlying cardiomyopathies,60 in particular 
when ejection fraction appears preserved. While in patients 
Figure 8. Practical approach to grade diastolic dysfunction by echocardiography. Adapted from the EACVI/ASE recommendations 
for the evaluation of left ventricular diastolic function by echocardiography.53
LA: left atrial; vol: volume; DT: E wave velocity deceleration time; Av: average, Val: Valsalva manoeuvre; E: early mitral inflow velocity; e′: early 
diastolic mitral annular velocity; A: duration of the pulmonary flow reversal; Ar: pulmonary venous atrial flow reversal.
Figure 9. Transthoracic lung ultrasound reveals multiple 
sonographic B-lines (ultrasound lung comets, white arrows) in a 
patient with acute pulmonary oedema.
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with depressed systolic function all the strain components 
and LV twisting are severely reduced, in the presence of 
preserved LV systolic function (such as in early stages of 
restrictive cardiomyopathy (RCM) and hypertrophic cardi-
omyopathy (HCM)), radial strain is relatively reduced and 
longitudinal strain is markedly depressed, similar to that of 
patients with reduced ejection fraction, but circumferential 
strain is maintained and LV twisting appears to be normal 
or supra-normal, acting as a balancing mechanism to main-
tain ejection fraction in the normal range.61 Global longitu-
dinal strain (GLS) of subendocardial fibres should be 
therefore assessed in all patients with HF, especially when 
LV ejection fraction is preserved. Values < –16% indicate 
mild depression of GLS and values < –10% are consistent 
with a severe reduction of GLS. Of note, these values still 
require to be validated in the acute settings and are not 
applicable to patients with systolic HF being treated with 
inotropic agents or mechanical circulatory support. The 
evaluation of GLS is highly feasible and reproducible in 
this clinical setting while circumferential and radial strain, 
as well as LV twisting, are less reproducible.60 In certain 
cardiomyopathies a reduction of regional longitudinal 
strain is encountered. Thus, infiltrative cardiomyopathies, 
such as cardiac amyloidosis or Loeffler’s cardiomyopathy 
(eosinophilic infiltration), reveal a prominent reduction of 
regional longitudinal strain of the basal LV segments 
(Figure 10) while the reduction of GLS appears to be more 
generalized in HCM (Figure 11).
In patients with HCM, a comprehensive approach to 
assessing LV filling pressure is recommended, with consid-
eration of all echocardiographic data (i.e. pulmonary arte-
rial pressures, mitral inflow pattern, E/e′, etc.) according to 
the individual clinical context. In the acutely unwell HCM 
patient, LV outflow tract obstruction should be always 
excluded. Here continuous wave (CW) Doppler assessment 
of the LV outflow tract is used to determine the peak veloc-
ity at the site of obstruction, with an excellent correlation of 
pressure differences as measured by the CW Doppler 
Figure 10. Sample of regional longitudinal strain (APLAX: apical long-axis, 4CH: four-chamber view, 2CH: two-chamber view) a 
bulls-eye representation in a patient with cardiac amyloidosis. In the presence of a normal ejection fraction (56%), the reduction of 
regional longitudinal strain involves predominantly the basal segments of the left ventricle. In the left section of each view colour 
representation of quantitation of peak regional strain values (normally negative) referring to six myocardial regions is depicted. 
In the right upper section of each view regional colour systolic curves of systolic strain are marked while the dotted white line 
corresponds to average strain (GLPS). In the right lower section qualitative colour M-mode strain representation refers to the six 
consecutive myocardial segments: at the bottom left, ventricle (LV) basal right segments (red colour); at the central part, LV apex; 
at the top, LV basal segments (yellow colour); red and pink colour refers to systolic deformation.
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method and by cardiac catheterization. Colour flow map-
ping can be used to characterize the level of obstruction, 
either in the LV outflow tract (LVOT) or in the LV mid-
cavity. In patients with significant LV hypertrophy and 
potential for LVOT obstruction, this may be exacerbated in 
the presence of positive inotropic agents or hypovolaemia. 
This may be particularly important in the context of con-
comitant right HF, where resultant underfilling of the LV 
exacerbates the risk of dynamic LVOT obstruction. Here 
echocardiography is essential for diagnosis and monitoring 
the response to interventions.
The echocardiographic detection of intracardiac thrombi 
in patients affected by idiopathic cardiomyopathy (IDCM) 
and LV non-compaction is common when they present 
acutely with an ischaemic stroke. Spontaneous echo contrast 
(‘smoke’) is considered a pre-thrombotic condition, associ-
ated with an increased risk for thromboembolic events.62 As 
LV thrombi develop predominantly apically or in akinetic 
regions, TTE has superior diagnostic accuracy (sensitivity = 
90%, specificity = 85%)62 compared with TOE. The accu-
racy of TTE is further increased by using colour Doppler 
and/or intravenous contrast agents.13 Several echocardio-
graphic features must be evaluated in patients with LV 
thrombi (Figure 12) including shape (thrombus may be 
mural or protruding within the cavity), motion (thrombus 
may be fixed or present an independent motion to a variable 
extent) and also the presence of any adjacent LV aneurysm 
– a localized area of akinesia or dyskinesia that deforms the 
LV chamber during both systole and diastole.63 A higher risk 
of embolization is found in patients with larger thrombus 
size and/or thrombi which are mobile and protrude into the 
LV cavity, particularly in older patients.
In cardiomyopathy patients with atrial flutter and/or 
atrial fibrillation, atrial thrombi involve most frequently the 
LA cavity and LA appendage (LAA). TOE is the gold 
standard for diagnosis of LA and LAA thrombi, with high 
sensitivity and specificity. By using TOE, LAA thrombi 
appear as echogenic masses, distinct from the underlying 
endocardium, observed in more than one imaging 
plane. They should be distinguished from pectinate mus-
cles by using multiple planes of imaging. Here biplane 
imaging may be of use, particularly when evaluating an 
Figure 11. Regional longitudinal strain (bulls-eye representation) in a patient with hypertrophic cardiomyopathy. In the presence 
of a normal left ventricular ejection fraction (57%), the reduction of regional longitudinal strain involves left ventricle walls more 
homogeneously than in a patient with cardiac amyloidosis.
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anatomically complex LAA. Patients with mechanical cir-
culatory support should be evaluated for intracardiac 
thrombi, particularly related to cannulae, and also valves 
(including prosthetic valve) when the heart is not ejecting. 
This is highly specialized echocardiography and should 
only be undertaken by experts in the field.
Key points regarding the emergency echocardio-
graphic evaluation in patients with suspected 
cardiomyopathies:
 • Calculate 2D LV ejection fraction and additional 
signs of LV systolic dysfunction (sphericity 
index, pulsed tissue Doppler derived s′ velocity 
of mitral annulus, indexed stroke volume).
 • Take into account LV geometry and possible 
regional differences of myocardial wall 
thickness.
 • Estimate LV filling pressure (E/e′ ratio, AR – 
A duration difference, LA volume index, pul-
monary arterial systolic pressure).
 • Take into account reduction of GLS, even in 
the presence of normal ejection fraction.
 • Actively diagnose/exclude LVOT obstruction 
in patients with HCM/LV hypertrophy.
 • Take into account the level and degree of car-
diorespiratory support.
Figure 12. 3D transthoracic echocardiography showing a thrombus located in the left ventricular apex in a patient with recent ST 
segment elevation myocardial infarction of the anterior wall. See also video 4 online.
Pulmonary embolism. The diagnosis of acute pulmonary 
embolism is challenging in the emergency room since both 
symptoms (dyspnoea and/or chest pain) and clinical signs 
are not specific.64 If available, TTE can help to establish a 
prompt diagnosis and to identify patients with high-risk 
features. Overall, the sensitivity of TTE for the diagnosis of 
pulmonary embolism is about 50–60% while the specificity 
is around 80–90%. In some situations, that is, critically ill 
patients, TOE may improve the sensitivity.65 Of note, TTE 
is normal in about 50% of unselected patients with acute 
pulmonary embolism, but it can provide direct and/or indi-
rect evidence for the diagnosis. The visualization of a large, 
mobile, serpentine thrombus trapped in the right heart 
chambers or pulmonary artery is rare, but makes the diag-
nosis evident.66 In general, although other diagnostic tests 
(CT, D-dimer, V/Q scanning) are used to confirm the diag-
nosis, echocardiography is valuable as a complementary 
imaging technique. Where the patient is catastrophically 
haemodynamically unstable, TTE may be the only immedi-
ately available and appropriate imaging investigation.67
The main indirect findings for pulmonary embolism are 
the consequences of acutely increased pulmonary artery/
right heart pressures. Although non-specific, they include: 
dilatation of right heart chambers (i.e. abnormal ratio of 
RV diameter or area to LV diameter or area and of the infe-
rior vena cava), RV hypokinesia, abnormal motion of the 
interventricular septum. In a patient with a relevant history 
and clinical findings, a ratio between end-diastolic RV to 
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LV diameter >0.6, and a ratio of end-diastolic RV to LV 
area >1.0 are consistent with massive pulmonary embo-
lism68 (Figure 13). In pulmonary embolism, RV hypokine-
sia is not necessarily global but can be limited to the mid 
RV free wall while contraction of the RV apex may be nor-
mal or hyperdynamic (McConnell sign).69 Although previ-
ously thought to be specific for the diagnosis of pulmonary 
embolism, this is now questioned, since it can be seen in 
other conditions. Where pulmonary embolism is diag-
nosed, echocardiography can be used to differentiate those 
patients not at high risk into intermediate risk (evidence of 
RV dysfunction) versus low risk (no RV dysfunction). In 
patients with suspected high-risk pulmonary embolism 
presenting with shock or hypotension, the absence of 
echocardiographic signs of RV pressure overload or/and 
dysfunction virtually excludes massive pulmonary embo-
lism as a cause of haemodynamic instability.
Secondary tricuspid regurgitation is frequent in patients 
with intermediate to high risk pulmonary embolism. It allows 
the estimation of RV systolic pressure and thus of pulmonary 
arterial systolic pressure (PAsP) in the absence of pulmonary 
valve stenosis. PAsP can be estimated from the peak velocity 
of the tricuspid regurgitant jet (V) according to the simplified 
Bernoulli equation, but may underestimate when tricuspid 
regurgitation is very severe. Right atrial pressure is estimated 
by clinical examination of the jugular veins, by the diameter of 
the inferior vena cava and its respiratory changes, or poten-
tially by direct measurement from central venous catheteriza-
tion in the critically ill. As the RV is only able to generate a 
PAsP of up to 60 mmHg acutely, in the acute setting the tricus-
pid regurgitant jet velocities are expected to be no higher than 
2.5–3.5 m/s, corresponding to a PAsP of about 40–50 mmHg 
in acute pulmonary embolism. Conversely, a PAsP >60 mmHg 
may suggest a more chronic process, relating to repeated epi-
sodes of pulmonary embolism (Figure 13) or a chronic pulmo-
nary parenchymal disease and/or super-added pulmonary 
embolism. Other modalities such as Doppler myocardial 
imaging and strain may add significant information relating to 
RV function evaluation; however, these techniques remain 
experimental, in particular in the acute setting.
Figure 13. Echocardiographic examination of a patient admitted for recurrent episodes of pulmonary embolism. The right 
ventricle (RV) was enlarged as compared with the left ventricle (LV) and the ratio between end-diastolic RV to LV diameter > 
0.6. The transtricuspid pressure gradient (TTPG) was markedly increased, indicating chronic severe pulmonary hypertension. 
Tricuspid annular plane systolic excursion was found to be lower (8 mm vs. 11 mm) than the one measured on the echocardiogram 
one month previous to this admission. On the basis of the decrease in RV systolic function, recurrent pulmonary embolism was 
suspected. See also videos 5 and 6 online.
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Recommendations for echocardiography in patients 
with suspected/confirmed pulmonary embolism:
Recommended:
1. Suspected high risk of pulmonary embolism 
where shock or hypotension are present and 
CT is not immediately available (#);
2. For distinguishing cardiac versus non-cardiac 
aetiology of dyspnoea in patients in whom all 
clinical and laboratory clues are ambiguous;
3. For guiding the therapeutic option in patients 
with pulmonary embolism at intermediate 
risk.
Reasonable:
1. Search for pulmonary emboli and suspected 
clots in the right atrium or ventricle or main 
pulmonary artery branches;
2. For risk-stratification in non-high risk pulmo-
nary embolism.
Not recommended:
1. For elective diagnostic strategy in haemody-
namically stable, normotensive patients with 
suspected pulmonary embolism.
#TOE may be indicated when TTE studies are non-
diagnostic, catastrophic decompensation may occur 
with sedation.
Pneumothorax. Pneumothorax (PTX) is a potentially life-
threatening condition in patients admitted to the emergency 
department for acute dyspnoea with or without chest pain, 
in patients following central line insertion, and/or in 
patients with lung injury undergoing positive pressure ven-
tilation. Over the last decade, the use of ultrasound as a 
technique to evaluate PTX has rapidly evolved.14,70 In a 
normal lung, the two pleural layers are closely opposed, 
and ultrasound shows the movement of the parietal over the 
visceral pleura synchronized with respiration (lung/pleural 
sliding). When air separates the two layers the parietal 
pleura is still visualized, but lung sliding is not seen. 
Absence of lung sliding is required for the sonographic 
diagnosis of PTX, but its absence does not necessarily con-
firm PTX, since several other conditions (massive atelecta-
sis, main bronchus intubation, pleural adhesions) may also 
result in absence of lung sliding. Additional sonographic 
signs of PTX, which increase sensitivity of ultrasound and 
are required for diagnosis, include the following: 1) absence 
of B-lines, 2) absence of lung pulse, and 3) presence of lung 
point. Opposition of the parietal and visceral pleura is nec-
essary to visualize B-lines, therefore the presence of even 
one isolated B-line excludes PTX in the area scanned.71 
The lung pulse refers to the rhythmic movement of visceral 
upon parietal pleura and underlying lung tissue, synchro-
nous with the cardiac rhythm. PTX is characterized by the 
absence of both lung sliding and the lung pulse as the intra-
pleural air does not allow transmission of any movements 
to the parietal pleura. Thus, visualization of lung pulse 
excludes PTX in the area scanned.14 The lung point is the 
point on the chest wall where the normal pleural interface 
contacts the edge of the PTX. Using B-mode ultrasound, 
the lung point will appear as the boundary between normal 
lung sliding and PTX pattern (absence of lung sliding and 
of B-lines). The lung point represents the physical limit of 
PTX as mapped on the chest wall and is the most specific 
sonographic sign of PTX.72 In the emergency setting, the 
combination of lung sliding and lung pulse coupled with 
the presence of B-lines allows prompt and safe exclusion of 
a PTX (in the area scanned) without the need for searching 
the lung point. If tension pneumothorax is suspected in the 
haemodynamically unstable patient, it should be treated 
clinically, rather than relying on ultrasound features, in par-
ticular where the sonographer is not an expert in the field.
Heart–lung interactions and ventilation. Most of the patients 
who are ventilated have problems in weaning from mechan-
ical ventilation, depending upon the type of intensive care 
unit concerned. Although alveolar oedema is the most fre-
quently cited cardiac cause of failure to wean, additional 
cardiac-related factors also contribute. Determining the 
cardiac contribution can be challenging and echocardiogra-
phy can be pivotal to weaning success. However, this 
demands understanding the effects of normal and mechani-
cal ventilation upon the pressure/volume relations of the 
heart, and the physiological changes when transitioning 
from mechanical to spontaneous ventilation.
Cardiac output is predominantly determined by the 
pressure difference between mean systemic pressure and 
right atrial pressure, and so during normal inspiration, as 
this pressure difference increases, venous return corre-
spondingly increases. The increased volume in the right 
heart results in correspondingly reduced flows in the left 
heart due to ventricular–ventricular interaction. During 
positive pressure ventilation, these changes are reversed, 
and application of constant positive pressure (i.e. positive 
end-expiratory pressure (PEEP)) results additionally in a 
fall in venous return throughout the cardiac cycle. 
Additionally, the increase in transpulmonary pressure 
increases RV afterload, resulting in reduced right heart 
ejection. The corresponding increase in intrathoracic pres-
sure decreases LV afterload and increases LV preload, 
resulting in an increase in left heart ejection. These cycli-
cal changes are readily demonstrated using Doppler echo-
cardiography, and form the basis of diagnosing echo 
features of tamponade, excessive ventilatory pressures and 
predicting volume responsiveness.
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Evaluation of failure to wean from mechanical ventila-
tion therefore involves first demonstrating/excluding the 
presence of significantly elevated LA pressure (either at 
rest or on weaning), and then demonstrating/excluding the 
underlying cardiac causes of weaning failure that are 
potentially reversible. Estimation of LA pressure in this 
patient population remains, however, complex, and few 
techniques have been fully evaluated in this context. 
Factors to be considered have been described in 
Cardiomyopathies above. In all cases, the confounding 
factors of critical illness (heart rate, cardiac output, LV 
compliance, volume status and ventilation) have not yet 
been fully evaluated in this context.73
Physiological stress echocardiography (targeted echo-
cardiography during a weaning trial) may be limited by 
tachycardia, tachypnoea and patient agitation. Here, other 
modalities of stress may be required. Pharmacological 
stress echocardiography has been used in the critically ill, 
and can be applied even in patients on positive inotropic 
support (ACCs above). Where dynamic mitral regurgita-
tion is suspected (Cardiogenic shock complicating AMI 
below), volume and pressure loading may be used to reveal 
the nature, severity and dynamic nature of regurgitation. 
Other causes of weaning failure should be actively sought 
including progressive LV and/or RV dysfunction, exces-
sive tachycardia/bradycardia for the patients’ pathology 
(Cardiac arrhythmias section below), or development of 
outflow tract obstruction (LVOT obstruction below). 
Additional features that should be sought include exclu-
sion of dynamic intra-cardiac shunting with resultant dis-
proportionate hypoxia, and exclusion of the presence of 
intrapulmonary shunting.
Recommendations for echocardiography in patients 
with acute dyspnoea:
Recommended:
1. For distinguishing cardiac versus non-cardiac 
aetiology of dyspnoea in patients in whom 
clinical and laboratory clues are ambiguous/
non conclusive;
2. Assessment of LV size and function in 
patients with suspected clinical diagnosis of 
HF;
3. To assist in determining the cause of failure to 
wean from mechanical ventilation.
Not recommended:
1. Evaluation of dyspnoea in patients for which 
a non-cardiac aetiology is apparent.
Note: TOE is indicated when TTE studies are not 
diagnostic.
Haemodynamic instability and 
shock
When dealing with patients with hypotension and shock, 
prompt determination of the underlying cause can be life-
saving as it allows timely initiation of appropriate treat-
ment. Here, echocardiography permits rapid assessment of 
cardiac structure and function, global and regional ventric-
ular wall motion, cardiac chambers size, valvular disease 
and the presence or absence of a pericardial collection. 
Currently, TTE rather than TOE should be considered as 
the initial imaging in unstable patients. TOE is indicated 
when TTE is of non-diagnostic value and when the patient 
is intubated and ventilated. Shock can be broadly catego-
rized into hypovolaemic, cardiogenic, distributive (e.g. 
anaphylactic, septic, neurogenic) and obstructive.
Hypovolaemic shock
Hypovolaemic shock is caused by a critical decrease in intra-
vascular volume (i.e. haemorrhage, inadequate fluid intake, 
external fluid loss). Diminished venous return (preload) 
results in decreased ventricular filling and reduced stroke 
volume. Unless compensated for by an increase in heart rate, 
cardiac output falls. In hypovolaemia, echocardiography can 
rapidly document a small hyperdynamic unloaded ventricle, 
with a reduced LV end-diastolic area. There are a number of 
caveats, however, in using this feature to diagnose hypovol-
aemia and potential volume responsiveness, and the tech-
nique should only be applied in the context of a normal LV. 
In profound hypovolaemia (likely to respond to volume 
loading by an increase in cardiac output) the inferior vena 
cava diameter may be small (<10 mm) with inspiratory col-
lapse in spontaneously breathing patients. In mechanically 
ventilated patients with hypovolaemia, the inferior vena cava 
might also be of small diameter but at end expiration and 
with variable respiratory change (depending on adaptation to 
ventilator).74 As with interpretation of LV end-diastolic area 
to predict volume responsiveness, there are a number of 
exclusions to application of this technique in the critically/
acutely ill patient population, particularly when cardiac/car-
diopulmonary pathology co-exists. They are not applicable 
when the patient is interacting with the ventilator.
Distributive shock, sepsis and the sepsis 
syndromes
Distributive shock is caused by an insufficient intravascular 
volume of blood secondary to vasodilation. Septic shock is 
the commonest cause. It is frequently associated with rela-
tive hypovolaemia (loss of intravascular volume due to cap-
illary leak), relatively high cardiac output (except potentially 
in the presence of cardiac disease) and hyperkinetic biven-
tricular systolic function. The LV is rarely dilated, unless an 
underlying chronic cardiac dysfunction in present. In some 
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patients, diffuse transient hypokinesia might be observed, 
but the cardiac output may still be high or normal.75 In other 
conditions, the absence of hyperdynamic LV and RV sys-
tolic function often underlines relative myocardial func-
tional impairment. Some degree of pulmonary hypertension 
and/or elevated pulmonary vascular resistance is common. 
RV systolic dysfunction may develop in up to one-third of 
patients. Intrinsic depression of RV myocardial function is 
detected as RV hypokinesia, and semi-quantitatively appre-
ciated as variable degree of RV dilatation. Septic shock can 
be associated with endocarditis or line/cannula infection, as 
well as related to other systemic causes of infection. In sep-
sis accompanying pneumonia, when respiratory failure 
supervenes assessment of ventricular function should antici-
pate the potential requirement for extracorporeal respiratory 
support, with the requirement that the RV is able to tolerate 
a significant additional volume load (up to approximately 
4l/min). Here, advanced assessment of RV function is 
required. Emerging studies have suggested the potential use 
of speckle tracking to detect ventricular dysfunction in sep-
tic shock not appreciated by conventional echocardiogra-
phy. In these studies, despite no demonstrable difference in 
fractional shortening and ejection fraction between controls 
and children with sepsis, significant abnormalities in cir-
cumferential and longitudinal strain, strain rate, radial dis-
placement and rotational velocity and displacement have 
been demonstrated.76
In patients with clinical features of endocarditis and/or 
at high risk of endocarditis expert echocardiography should 
be undertaken to exclude valvular endocarditis as a cardiac 
source of sepsis (New cardiac murmur section below). 
Detection of infection in the presence of indwelling lines 
and cannulae can be challenging. It is common for patients 
to develop thrombus associated with indwelling central 
venous cannulae, and fibrin strands are frequently seen on 
implanted pacemaker devices. Determination of line/wire/
cannula infection can be challenging and may not be pos-
sible using echocardiography only. Here, the presence of 
new/persisting sepsis with progressive enlargement of 
mobile masses despite anticoagulation may suggest the 
diagnosis. Where endocarditis is suspected, but TOE is 
negative in patients with permanently implanted devices, 
intracardiac echocardiography has been proposed; how-
ever, its use in critically ill endocarditis patients has not 
been evaluated.77
Obstructive shock
Mechanical factors that interfere with filling (tamponade, 
mediastinal masses, inferior or superior vena cava com-
pression or thrombosis, tension PTX, severe asthma, intra-
cardiac tumours or clot) or emptying (acute massive 
pulmonary embolism, aortic stenosis, LVOT obstruction) 
of the heart or great vessels may cause obstructive shock 
(Figure 14). As a result of the low cardiac output, the patient 
will be tachycardic with signs of tissue hypoperfusion and 
will have an increase in systemic vascular resistance to 
compensate.
LVOT obstruction. There is a subset of patients (many of 
them with a history of hypertension and LV hypertrophy, or 
with previous aortic valve replacement) who with volume 
depletion develop dynamic LVOT obstruction, with sys-
tolic anterior motion of the mitral valve and secondary 
mitral regurgitation, resulting in a progressive fall in car-
diac output. Here, right heart catheterization (increased pul-
monary capillary wedge pressure resulting from mitral 
regurgitation and the hyperdynamic non-compliant LV) 
may be misleading and may result in inappropriate deci-
sion-making (i.e. administration of inotrope agents instead 
of a beta-blocker and intravenous fluids). There should be a 
high index of suspicion in such patients, especially where 
they fail to increase cardiac output in response to escalating 
inotropic support. Echocardiography is diagnostic.
Cardiac tamponade. Cardiac tamponade results from impor-
tant and/or rapid accumulation of fluid in the pericardial 
space that increases intrapericardial pressure above intra-
cavitary pressure, resulting in an important fall in transmu-
ral pressure. Therefore, chamber filling is reduced and 
cardiac output is compromised. Compensatory tachycardia 
and vasoconstriction initially maintain a normal cardiac out-
put; however, at a critical level of intrapericardial pressure, 
cardiac output and arterial pressure fall. The inspiratory 
increase in venous return to the heart increases RV volumes, 
and because of the resultant septal shift (ventricular interde-
pendence) LV filling is reduced, such that LV stroke vol-
ume subsequently falls, and pulsus paradoxus may result 
Figure 14. Mediastinal mass in a patient presenting with 
obstructive shock. Note the compression of the left atrium 
(LA) by a round mass localized behind the LA but in front of the 
descending thoracic aorta.
Ao: aorta; LV: left ventricle
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(>10 mmHg fall in systolic blood pressure with inspiration). 
These clinical features correspond to some of the echocar-
diographic findings.78
There are several 2D-echo findings that suggest a 
haemodynamically significant pericardial collection. 
Although a large pericardial collection is more likely than a 
small collection to be associated with increased intraperi-
cardial pressure, this depends mainly upon the rate of accu-
mulation. Hence, a patient with malignant pericardial 
effusion may have minimal/no haemodynamic compro-
mise, while a patient who has sustained RV perforation dur-
ing pacing may develop cardiogenic shock with only a 
small/minimal collection. The most sensitive sign of tam-
ponade is cyclic compression, inversion or collapse of the 
right atrium, where chamber collapse in late diastole per-
sisting into early ventricular systole occurs in the case of 
severely increased intrapericardial pressure. This sign is of 
only moderate specificity, however. Although diastolic RV 
collapse (inward diastolic motion of the RV free wall) 
occurs later, it is a more specific sign and is best appreci-
ated from the parasternal or subcostal long-axis views. 
Dilatation of the inferior vena cava without change during 
deep inspiration has a reasonable sensitivity but only a 
moderate specificity for the diagnosis of tamponade (in the 
absence of concomitant right-sided disease), which is fur-
ther reduced in the positive pressure ventilation setting. 
Pulsed wave Doppler provides additional information in 
the diagnosis of tamponade. Here changes in transvalvular 
velocities during respiration (best recorded at low speed) 
include inspiratory increase in RV inflow velocity (> 35–
40%) as well as a parallel (but slightly delayed for transpul-
monary transit) reduction during inspiration of LV inflow 
and aortic ejection velocities. Of note, such phasic changes 
in flow with respiration are reversed in positive pressure 
ventilation.
If the patient’s condition requires urgent pericardiocen-
tensis, the procedure may be echocardiographically guided, 
as this has been shown to reduce complications.78 
Echocardiography can be used to determine the deepest 
part of the collection and the distance between the patient’s 
skin and the collection. If necessary, the position of the 
pericardial needle can be visualized and in the case of 
doubt, agitated saline contrast can be injected to confirm 
the intrapericardial position of the needle/cannula. 
Echocardiography can additionally be used to verify 
whether the collection has been completely drained. TOE is 
rarely indicated in this setting.
Post-cardiac surgery is a special consideration, where 
collections may be small and localized, and early post-
operative echocardiographic features of tamponade may be 
absent (even in the presence of profound haemodynamic 
compromise). Reliance on TTE potentially leads to misdi-
agnoses, and where suspected, the patient should undergo 
either immediate surgical exploration or TOE prior to inter-
vention where the surgeon requires.
Cardiogenic shock. Cardiogenic shock is a state of inade-
quate cardiac output to meet the demands of the tissues. 
The commonest cause remains severe LV systolic dysfunc-
tion secondary to AMI. Shock due to LV dysfunction 
remains the leading cause of mortality in AMI (50–70%).79 
Other causes include RV dysfunction, mechanical compli-
cations of AMI, cardiomyopathy, severe valvular heart dis-
ease, myocarditis, myocardial contusion and acute aortic 
dissection. Echocardiography is an excellent initial tool for 
confirming the diagnosis of the cause of cardiogenic shock, 
providing additional information regarding the haemody-
namic status of the patient (including filling pressures and 
stroke volume) and ruling out other causes of shock; there-
fore, immediate TTE should be performed when cardio-
genic shock is suspected. Where TTE is suboptimal, TOE 
may be indicated.
Cardiogenic shock complicating AMI. In the setting of AMI, 
there are a number of causes of cardiogenic shock, includ-
ing reduction in LV function, RV infarction, acute severe 
mitral regurgitation and mechanical complications: LV free 
wall rupture, ventricular septal rupture, and papillary mus-
cle rupture.
LV dysfunction. Cardiogenic shock may result from 
the acute loss of a major percentage of cardiomyocyte 
function (at least 40% of the LV) or the additive loss 
of myocardial function in a previously damaged LV. 
Either extensive myocardial necrosis or stunned non-
functional but viable myocardium may contribute to 
post-AMI shock. This is manifested on echocardiogram 
by a depressed LV global (ejection fraction) and regional 
function (regional wall motion abnormality), a decrease 
in stroke volume and cardiac output, elevated LV fill-
ing and pulmonary pressures with or without secondary 
mitral regurgitation. Both LV ejection fraction and the 
severity of mitral regurgitation are major predictors of 
mortality; however, admission ejection fraction does not 
correlate with outcome.80
RV infarction. RV infarction is most often associated 
with inferior AMI but rarely may be an isolated condition. 
Echocardiography may show RV dyssynergy, dilatation, 
paradoxical septal motion, and McConnell sign. A decrease 
of tricuspid annulus systolic excursion (TAPSE) is usually 
present. The diagnosis may also be suspected when a tri-
cuspid regurgitation with low pulmonary pressure, associ-
ated with pulmonary regurgitation with a steep pressure 
half-time, is demonstrated. Assessment of LV function in 
the context of acute, severe RV dysfunction can be chal-
lenging as the LV may be relatively unloaded. Care must 
be taken when extracorporeal support is being considered, 
as when a right-ventricular assist device (RVAD) is used, 
the increased volume delivered to the LV may reveal sig-
nificant LV dysfunction.
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Free ventricular wall rupture. Free ventricular wall rup-
ture is the most serious complication following AMI but 
its presentation may range from an acute sudden cata-
strophic collapse with electrical-mechanical dissocia-
tion to an insidious pericardial effusion with or without 
accompanying hypotension. Echocardiography may 
sometimes demonstrate overt cardiac tamponade or only 
a pericardial collection in subacute free wall rupture 
(30% of rupture). Thus, the presence of pericardial col-
lection in the setting of AMI should raise the suspicion 
of subacute ventricular wall rupture, and careful scanning 
for wall rupture should be performed. A pericardial col-
lection in this setting may consist of blood/thrombus and 
be localized inferiorly, presenting a potential diagnostic 
challenge.
Acute mitral regurgitation. Acute mitral regurgitation is 
a potentially life-threatening complication of AMI.80 It is 
most commonly secondary (functional) to LV dysfunc-
tion without structural valvular abnormalities, resulting 
from increased leaflet tethering and decreased mitral clos-
ing forces. When present, secondary mitral regurgitation 
may exhibit a range of severity, and is frequently dynamic, 
being reduced in the presence of positive pressure ventila-
tion. Even a mild degree of mitral regurgitation in the acute 
setting of MI is associated with a worse prognosis. More 
rarely mitral regurgitation can result from acute papillary 
muscle dysfunction or rupture. Rupture of the posterior 
papillary muscle (supplied by a single coronary artery) is 
by far the more common, and can be complete or partial. 
Echocardiography demonstrates a partial or complete flail 
of the mitral valve. The diagnosis is made when a triangu-
lar mobile structure representing the head of the papillary 
muscle attached to the tip of the flail leaflet prolapses into 
the LA during systole. Colour Doppler usually shows an 
eccentric jet directed away from the defective leaflet (anter-
oseptally directed jet of mitral regurgitation in the case of 
posterior flail leaflet). Where catastrophically severe, the 
colour jet may underestimate the severity of mitral regur-
gitation, as pressures between the two chambers rapidly 
equilibrate.
Acute mitral regurgitation can additionally result from 
acute systolic anterior motion of the mitral valve secondary 
to dynamic LVOT obstruction. Here the echo reveals an 
increased flow velocity across the LVOT and a typical late-
peaking dagger-shaped CW Doppler profile (from the api-
cal view). The severity of mitral regurgitation can range 
from mild to severe. The jet typically arises centrally but 
may take an eccentric course in the LA (directed towards 
the LA lateral wall). Flow duration and Doppler spectral 
configuration help to differentiate mitral regurgitation from 
LVOT obstruction. In mitral regurgitation, the rising slope 
at mid-systole is usually perpendicular to the baseline, 
whereas it is curvilinear until it reaches the highest velocity 
in the LV outflow signal. Moreover, the mitral regurgitation 
signal extends beyond the ejection period while its onset 
occurs earlier than the flow of dynamic LV obstruction. The 
evaluation of the severity of acute mitral regurgitation is 
described elsewhere.81 The other mechanical complications 
of AMI have been discussed elsewhere.80,81
Recommendations for echocardiography in patients 
with shock:
Recommended:
1. For differential diagnosis of the cause of 
hypotension or shock, by detecting cardiac or 
non-cardiac aetiologies;
2. For differentiating the different cardiac causes 
of cardiogenic shock and guiding appropriate 
therapy, including surgical intervention when 
indicated.
Note: TOE is indicated when TTE studies are not 
diagnostic.
New cardiac murmur
Cardiac murmurs may be due to valvular heart disease, 
increased flow across a normal valve or shunts related to 
congenital or acquired defects. A murmur in a patient with 
acute cardiorespiratory symptoms or clinical signs sug-
gesting structural heart disease is a definite indication for 
echocardiography. It provides valuable information regard-
ing valvular morphology and function, aetiology of valve 
disease, quantification of valvular lesions, chamber size 
and ventricular function, wall thickness and pulmonary 
artery pressures.82 Echocardiography also readily detects 
associated structural abnormalities such as fibrosis, calci-
fication, thrombus or vegetation and abnormalities of val-
vular motion such as immobility, flail or prolapsing 
leaflets, or prosthetic valve dehiscence. The evaluation of 
valvular disease is extensively described in appropriate 
EACVI recommendations.81
Valvular disease leading to intensive care admission is 
likely to be severe, and predominantly affecting the left-
sided valves. Both aortic and mitral regurgitation are the 
most common relevant acute valvular regurgitation; how-
ever, with increasing surgery for valvular disease, the inci-
dence of prosthetic valve dysfunction is increasing.81 
Critical aortic stenosis may lead to intensive care admission 
where acute decompensation occurs, or may be an inciden-
tal finding in a patient admitted for other reasons. Acute 
decompensation due to mitral stenosis is generally related 
to the onset of atrial fibrillation, and/or an increase in circu-
lating volume (for example in pregnancy). Right-sided val-
vular pathology rarely leads to decompensation of the 
patient to the extent that admission is indicated per se, but 
the underlying pathology (i.e. endocarditis) may be the trig-
ger for admission to the intensive care unit.
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Valvular regurgitation
Acute mitral regurgitation can complicate an AMI or 
develop during an episode of transient myocardial ischae-
mia involving the posterior and lateral LV wall. Acute 
mitral regurgitation can also result from spontaneous 
chordal rupture (degenerative or rheumatic mitral valve), 
infective endocarditis, acute HF (systolic or diastolic), and 
trauma, or mitral prosthetic dysfunction. Acute aortic regur-
gitation usually results from acute aortic dissection, trauma, 
infective endocarditis and rupture of a congenital valve fen-
estration or degeneration of previous bioprosthetic replace-
ment. Where new mitral or aortic regurgitation occurs in 
the setting of acute clinical symptoms, there should be a 
high index of suspicion for infective endocarditis. TTE is 
mandatory in this setting,83 and should be performed as 
soon as the diagnosis of infective endocarditis is suspected. 
TOE should be undertaken where there is diagnostic doubt 
and/or in planning the surgical strategy. TOE is indicated in 
particular when interrogation of a valve prosthesis is 
required. In addition to its major diagnostic value, echocar-
diography is also useful for assessing the cardiac conse-
quences of the valve destruction, the prognosis and the risk 
of embolism. Finally, in the setting of acute cardiac care, 
echocardiography will help the clinician in the decision and 
timing for surgery.
Echocardiographically, the major difference between 
acute and chronic severe valvular regurgitation is the extent 
of cardiac chamber enlargement and the magnitude of LV 
or LA pressure increase. With acute mitral regurgitation, 
and in the absence of intrinsic LV systolic or diastolic dys-
function, the LV and the LA dimensions are normal or 
mildly increased. The evaluation of regurgitation severity is 
complex, should integrate several parameters and be inter-
preted in the context of the cardiorespiratory support of the 
patient, as positive pressure ventilation and pharmacologi-
cal agents used for sedation/analgesia can significantly 
reduce the severity of mitral regurgitation. TOE might be 
necessary to accurately determine valve anatomy in some 
cases. Mitral regurgitation is also almost always severe in 
cases of papillary muscle rupture. Although colour flow 
imaging is helpful in detecting the presence and direction 
of regurgitant jet, colour Doppler may underestimate the 
severity in very severe regurgitation, and eccentric jets are 
more difficult to qualitatively examine. Therefore, the col-
our flow area of the regurgitant jet is not recommended to 
quantify the severity of acute aortic or mitral regurgitation. 
When feasible, measurement of the vena contracta and the 
PISA method are the recommended approaches to quantify 
both aortic and mitral regurgitation. For aortic regurgita-
tion, a vena contracta width >6 mm or an effective regurgi-
tant orifice area ≥ 30 mm² indicates severe regurgitation. 
For mitral regurgitation, a vena contracta width >7 mm or 
an effective regurgitant orifice area ≥ 40 mm² indicates 
severe regurgitation. However, it should be emphasized 
than a modest mitral regurgitant volume that develops 
acutely into a small non-compliant LA may cause severe 
pulmonary congestion and systemic hypotension, and that 
manipulation of the circulation and positive pressure venti-
lation may significantly alter the haemodynamics of the 
patient and echocardiographic findings.
Other more valve specific Doppler approaches can help 
in consolidating the impression of the degree of regurgita-
tion. In mitral regurgitation, an early truncation of mitral 
regurgitant velocities and pulmonary venous systolic flow 
reversal are particularly informative. In aortic regurgita-
tion, a short aortic insufficiency pressure half-time (<200 
ms) and a diastolic flow reversal in the descending aorta 
(end-diastolic velocity > 20 cm/s) are helpful. In acute 
severe aortic regurgitation, premature diastolic opening of 
the aortic valve and premature closure of the mitral valve 
with diastolic mitral regurgitation are particularly associ-
ated with catastrophic regurgitation. In the case of very 
severe regurgitation, echocardiographic parameters will 
additionally suggest a high LA pressure (short isovolumet-
ric relaxation time (IVRT), LV mitral inflow showing a 
restrictive pattern with an increased E velocity > 1.5 m/s, 
lung ultrasound suggesting interstitial oedema). Advantages 
and limitations of the various echo Doppler parameters 
used in valvular regurgitation are defined in the ESC/EACI 
guidelines, but evaluation must always consider the venti-
latory, pharmacological and mechanical support of the 
patient before grading severity.81, 84
Careful evaluation of valvular regurgitation is required 
in patients in whom mechanical circulatory support is indi-
cated. Here, even mild aortic regurgitation may be impor-
tant as it becomes continuous when the heart does not eject, 
and may lead to progressive LV dilatation.81
Valvular stenosis
Once the diagnosis of severe valvular disease demanding 
intervention is made85 echocardiography provides informa-
tion that shows whether the patient’s anatomy is suitable 
for transcatheter intervention.86,87 In the acutely unwell car-
diac patient, the indications for transcatheter intervention 
are limited, but potentially lifesaving, and include percuta-
neous mitral commissurotomy (PMC) and balloon aortic 
valvuloplasty (BAV), potentially with a view to definitive 
procedural intervention at a later date.
Significant mitral stenosis. Significant mitral stenosis may 
mimic acute respiratory distress syndrome (ARDS), pre-
senting with poor gas exchange and bilateral pulmonary 
infiltrates; however, the history and clinical examination 
will usually suggest the underlying diagnosis. A precipitant 
for acute deterioration may be the onset of atrial fibrilla-
tion. Where the patient is in extremis, PMC is performed 
with good effect. Indeed, PMC is the treatment of choice as 
a bridge to surgery in high-risk, critically ill patients. Echo-
cardiography is the main method to assess the aetiology, 
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severity and consequences of mitral stenosis, in addition to 
determining anatomical suitability and excluding contrain-
dications to PMC. The details of valvular assessment and 
intra-procedural monitoring using echocardiography are 
published elsewhere.85
Critical aortic stenosis. Critical aortic stenosis may be the 
primary reason for intensive care/emergency admission, or 
may be an incidental finding in a patient presenting with 
other symptoms (i.e. fractured hip requiring surgery). The 
diagnosis may be challenging on the intensive care unit, 
particularly in a low cardiac output state; however, TTE 
findings are characteristics. Critical aortic stenosis can be 
managed using BAV as a bridge to surgery or transcatheter 
aortic valve implantation (TAVI) in haemodynamically 
unstable patients who are at high risk for surgery, or in 
patients with symptomatic severe aortic stenosis who 
require urgent major non-cardiac surgery.87 As in mitral 
stenosis, guidelines and recommendations for assessment 
of the suitability of the aortic valve for BAV have been 
published elsewhere.81-85
Recommendations for echocardiography in patients 
with cardiac murmur:
Recommended:
1. Acute cardiac/intensive care patients with 
cardiac murmurs and symptoms or signs of 
heart failure, myocardial ischaemia/infarc-
tion, syncope, thromboembolism, infective 
endocarditis, or clinical evidence of structural 
heart disease;
2. Where mitral regurgitation is suspected in a 
patient on positive pressure ventilation, stress 
echocardiography (volume and/or pressure 
loading) may be indicated;
3. In patients with critical aortic stenosis and 
cardiogenic shock echocardiography should 
be used to assess suitability for BAV;
4. In patients with severe mitral stenosis and 
cardiogenic shock and/or pulmonary oedema 
echocardiography should be used to assess 
for PMC;
5. In patients requiring extracorporeal mechani-
cal circulatory support minor degrees of val-
vular regurgitation (particularly aortic 
regurgitation) may be important and should 
be evaluated by an expert.
Prosthetic valve dysfunction
Haemodynamic instability in the presence of prosthetic valve 
replacement should raise suspicion of massive prosthetic 
obstruction or regurgitation, in addition to the possibility of 
prosthetic endocarditis in patients with sepsis. It is extremely 
unusual for right-sided valve disease to result in acute dete-
rioration/decompensation. Left-sided prosthetic dysfunction 
should be suspected where there is normalization of septal 
motion, in particular in the presence of a dynamic LV and 
features of pulmonary oedema and/or cardiogenic shock. For 
the general evaluation of prosthetic haemodynamics the 
reader is referred to the corresponding recommendations.88 
Prosthetic valves are more difficult to evaluate than native 
valves, and therefore in the setting of a possible prosthesis-
related emergency should be evaluated by an expert in both 
TTE and TOE.44
Prosthetic valve regurgitation. Prosthetic regurgitation is fre-
quently paraprosthetic, although sudden structural deterio-
ration of bioprosthetic valves may cause severe transvalvular 
regurgitation. In rare cases, fracture of mechanical prosthe-
ses may occur, leading to occluder (disc) embolization with 
massive regurgitation. Large paraprosthetic leaks are often 
associated with abnormally increased mobility/instability 
of the entire prosthesis (rocking) and are termed dehiscence 
(Figure 15). Abnormal mobility of the prosthesis sewing 
ring nearly always implies severe paraprosthetic regurgita-
tion. The severity of regurgitation may be difficult to judge 
especially in aortic prostheses using standard measures. 
The extent of the prosthetic circumference on short-axis 
views showing leakage may be used to estimate severity, 
with > 20% (corresponding to > 72°) of the circumference 
indicating severe regurgitation (Figure 16).89,90 In acute 
regurgitation of an aortic prosthesis, premature mitral valve 
closure may be detected and indicates catastrophic regurgi-
tation. New paraprosthetic leakage presenting in the acute/
emergency setting is predominantly due to endocarditis. In 
contrast to endocarditis for native valves, vegetations are 
frequently absent, with the only echocardiographic abnor-
malities being paraprosthetic regurgitation and/or valve 
instability.
Prosthetic valve obstruction. Since all prostheses represent 
some degree of obstruction to flow even if functioning nor-
mally, detection of true prosthetic obstruction can be chal-
lenging. Obstruction is generally due to either thrombosis 
(most frequently in mitral or tricuspid mechanical valves) 
or pannus. Direct observation of the valve mechanism is 
usually feasible for mitral and tricuspid prostheses, but may 
be challenging for valves in the aortic position, even with 
TOE, and in particular where mitral valve replacement co-
exists. In all cases, expert evaluation is indicated. Transpros-
thetic gradients have wide normal ranges, and true 
obstruction may present with gradients well within those 
limits. Further, concomitant prosthetic regurgitation or 
small-for-patient prostheses (patient–prosthesis mismatch) 
will lead to abnormally high velocities without true 
mechanical obstruction. This is more frequent with aortic 
mechanical prostheses than with other prostheses. Ideally, 
for each valve, comparison with previous (ideally at time of 
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implant) velocities should be undertaken and pressure 
recovery should be calculated where indicated.91 In particu-
lar where a patient is in a high cardiac output state, or sep-
tic, the increased cardiac output may lead to correspondingly 
increased velocities that do not relate to an increase in valve 
obstruction. Here, increased velocities across all valves will 
be noted. Prolonged acceleration times (interval from onset 
of ejection to peak ejection velocity > 100 ms; Figure 17) 
correspond well with prosthesis obstruction in mechanical 
aortic valve replacement. TOE and CT are particularly 
helpful in identifying thrombus or pannus in aortic prosthe-
ses and on the atrial side of mitral prostheses, and where 
doubt remains fluoroscopy of the mechanical prosthesis 
should be undertaken.
Recommendations for echocardiography in patients 
with suspected prosthetic valve dysfunction:
Recommended:
1. Urgent TTE is mandatory in all patients with 
suspected acute prosthetic valve dysfunction 
to define the extent and mechanism of regur-
gitation and/or obstruction.
2. TOE is required, except in cases where TTE 
is entirely conclusive.
3. Echocardiography should be used in parallel 
with other diagnostic techniques where uncer-
tainty exists regarding the mechanism of 
dysfunction.
4. If prosthetic obstruction is suspected, fluoros-
copy and/or CT should be considered.
Cardiac arrhythmias
In the critically ill patient population, heart rates that might 
be acceptable in the outpatient setting may be inadequate. 
Thus, where stroke volume is limited (for example restric-
tive RV) a relative tachycardia may be required to maintain 
adequate cardiac output. In this patient population heart 
rates of 100–120 beats/min may be required. Other 
Figure 15. Mechanical aortic prosthesis with rocking motion, indicating dehiscence (see arrows). Transthoracic parasternal long 
axis view, left: in systole, right: in diastole. See also video 7 online.
Figure 16. Same case as in Figure 15. The transoesophageal 
short-axis view of the aortic prosthesis shows on colour 
Doppler severe paraprosthetic regurgitation (approximately 
from 7 to 1 o’clock and thus 50% of the circumference). See 
also video 8 online.
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pathologies represent different challenges: a long diastolic 
time may be required to maintain a low LA pressure in 
mitral stenosis, a short diastolic time only required in LV/
RV restriction, and in any patient with temporally long 
mitral and/or tricuspid regurgitation, tachycardia may 
severely limit ventricular filling. When assessing any criti-
cally ill patient the optimal heart rate for that patient and 
their individual pathology at that time should be considered 
in order to maintain the optimal cardiac output at the lowest 
filling pressure. This may make echocardiographic evalua-
tion challenging, but it is unavoidable in some patients.
Atrial arrhythmias
Atrial arrhythmias, common in the acute setting, present 
challenging conditions for assessing cardiac function and 
haemodynamics especially when irregular (as in atrial 
fibrillation). The loss of atrial contraction and the beat-to-
beat changes in pre-load and LV contractility affect dias-
tolic filling and ejection. Excessively rapid and irregular 
heart rhythms really challenge accurate assessment of car-
diac function and filling pressures.92 In atrial fibrillation, 
respecting an average of about 10 consecutive heart beats 
(≥13 has been suggested93) with a view to allowing the use 
of echocardiographic parameters usually used in sinus 
rhythm to predict elevated filling pressures, except for the 
difference between duration of pulmonary vein A-velocity 
and mitral inflow A-velocity. E/e′ ratio (>13) and E/Vp 
(>1.4) indicate increased LV filling pressures. The use in 
critically ill patients should still be applied with caution. 
The pulmonary venous flow D-velocity deceleration time 
can also be measured (<220ms). Instead of measuring 10 
consecutive beats, measuring three consecutive beats at a 
heart rate around 70 beats/min might be adequate. A value 
of the E-velocity deceleration time ≤ 150ms has been 
demonstrated to predict elevated filling pressure in patients 
having a decrease in LV ejection fraction.58,94 The averag-
ing remains crucial for systolic as for diastolic function 
parameters assessment; however, other approaches have 
been proposed.95 The ‘index beat’ method uses the meas-
urement performed on the cardiac cycle following a pair of 
equal preceding cardiac cycles.
If atrial fibrillation duration is >48 h or there is doubt 
about its duration, TOE can be used to rule out intracardiac 
thrombus prior to cardioversion. This has been discussed 
elsewhere.44
Ventricular arrhythmias
Patients with ventricular arrhythmias require clarification 
of the aetiology of their arrhythmias for decision making 
and ongoing care. Echocardiography is one of the first 
investigations to be performed as soon as the arrhythmia is 
successfully terminated.
Ischaemia. Ischaemia is the most frequent cause of ventric-
ular arrhythmias, which can induce ventricular fibrillation 
(requiring immediate defibrillation), ventricular tachycar-
dia or atrial fibrillation. Echocardiography in the acute set-
ting may reveal globally or regionally reduced ventricular 
function related to the occluded/obstructed coronary vessel 
and immediate revascularization should be achieved (see 
Acute Coronary Syndromes (ACSs) above). In more chronic 
post-MI patients, scar tissue and reduced cardiac function 
are important foci for arrhythmogenecity. In the non-inten-
sive care setting, cardiac function by LV ejection fraction is 
the most used parameter for risk stratification of ventricular 
arrhythmias, future prognosis and decision making for 
implantable cardioverter defibrillator (ICD) in patients 
with previous MI. The best parameters in the critical care 
setting, in the context of inotropic and possibly ventilator 
support, are not known.
Non-ischaemic causes. Non-ischaemic causes should be con-
sidered in particular in individuals <35 years of age with 
ventricular arrhythmias. Inherited genetic cardiac disease is 
the most frequent cause of life threatening arrhythmias in 
this population, including HCM, arrhythmogenic RV cardio-
myopathy and familial dilated cardiomyopathy (DCM). In 
arrhythmogenic right ventricular cardiomyopathy (ARVC), 
echocardiography may reveal a dilated RV with reduced 
function, dilated RVOT and in progressive cases a thinning 
of the RV wall along with RV aneurysms and/or increased 
trabeculation of the RV (Figure 18). In HCM, echocardiog-
raphy typically shows symmetric or asymmetric hypertro-
phy, normal or slightly reduced ventricular volumes, diastolic 
dysfunction and increased atrial volumes.96 A hypertrophied 
interventricular septum or any segments with a wall thick-
ness >15mm in the absence of other explanatory diagnoses, 
such as hypertension or amyloidosis, makes the diagnosis of 
Figure 17. Transprosthetic continuous wave Doppler 
recording of a bi-leaflet mechanical aortic prosthesis with 
partial thrombotic obstruction (surgically confirmed). High flow 
velocities (peak 496 cm/s) and acceleration time (between red 
arrows) of 128 ms.
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HCM probable.97 Importantly, if no echocardiographic or 
other imaging abnormalities are found in a young patient 
with ventricular arrhythmias, ion channelopathies, the use of 
toxics or doping have to be considered. Echocardiography 
will be normal by standard means, but recent studies have 
shown that a prolonged and dispersed myocardial contrac-
tion can be visualized using strain echocardiography.98,99 
Detailed recommendations regarding standard echocardiog-
raphy in these cases are outlined in the appropriate EACVI 
guidelines.100
Traumatic injuries of the heart and 
aorta
Blunt or penetrating chest trauma may cause severe 
injury to the heart and great vessels. Both TTE and TOE 
play an important role in the assessment of patients with 
chest trauma, and TOE may be indicated in patients with 
polytrauma and/or on mechanical ventilation or when a 
traumatic acute aortic syndrome is suspected. Of all cases 
of blunt trauma resulting in substantial injury to the tho-
rax, motor vehicle collisions account for the majority, 
followed by falls from height, pedestrian–automobile 
collisions and crush injuries. It is important to distinguish 
aortic from cardiac injuries. With modern trauma centres 
and management, in severe trauma/polytrauma, rapid CT 
scanning allows rapid and wider visualization, and when 
immediately available is the imaging modality of choice. 
In those patients with unequivocal evidence of aortic 
injury, no further diagnostic imaging evaluation is neces-
sary. Unlike other imaging techniques, TOE can be used 
intraoperatively, supporting and informing surgical and 
anaesthetic decisions. Finally, TOE can help evaluate 
the myocardium for wall motion abnormalities and assess 
the haemodynamic consequences of pericardial collec-
tion.8,101 However, 5–25% of trauma patients have cervi-
cal spine fractures and in these patients TOE is 
contraindicated.8 The correct diagnosis additionally 
requires differentiation of aortic rupture from other con-
ditions that mimic its echocardiographic findings, such as 
aortic debris or atheromatous plaques. Also, traumatic 
pseudoaneurysms must be differentiated from true 
aneurysms.8
Acute traumatic aortic injuries
It is estimated that 75%–80% of thoracic aortic injuries 
are a result of motor vehicle collisions, either head-on or 
serious lateral impact. Acute traumatic aortic injury from 
blunt trauma is a substantial cause of morbidity and mor-
tality, being immediately lethal in 80%–90% of cases. If 
detected early, it is estimated that 60%–80% of patients 
who reach the hospital alive (usually showing an aortic 
pseudoaneurysm) will survive following definitive ther-
apy. Therefore, prompt recognition and treatment of these 
injuries are critical for survival.101 Though open surgical 
repair continues to be the mainstay of therapy, percutane-
ous endovascular stent-grafting repair is becoming fre-
quent in many trauma centres. Trauma may cause aortic 
rupture, dissection or intramural haematoma. Partial dis-
ruption of the aortic wall may lead to pseudoaneurysm. 
Although TOE is described in trauma patients with sus-
pected aortic injury, many patients will be undergoing CT 
routinely, and aortic imaging would be a part of the tho-
racic assessment protocol.
Understanding the mechanism of aortic injury is crucial 
to interpreting imaging findings. The sites of relative immo-
bility of the aorta (the aortic isthmus and ligamentum arte-
riosum, the aortic root and the diaphragmatic aorta) are the 
most affected by blunt trauma. The exact pathophysiology 
of thoracic aortic injuries is complex and probably results 
from the interplay of multiple mechanisms. An osseous 
pinch is caused by posterior translation of the sternum, 
which traps the aorta at the narrowest point of the thorax. 
Torsion is depicted in the ascending aorta resulting in twist-
ing above the fixed aortic valve. Compression of the lumen 
forces blood to run inferiorly, toward the aortic valve, result-
ing in a water hammer effect. At the ligamentum arteriosum, 
the aorta is affected by both bending and shearing stresses, 
augmented by the anatomic changes from the osseous pinch 
against the thoracic spine and pressure changes from the 
water hammer effect. The combination of forces is 
Figure 18. Dilated right ventricle (RV) with reduced function, dilated right ventricular outflow tract (RVOT) and thinning of the 
RV wall along with highly trabeculated RV apex and free wall are all signs of arrhythmogenic RV cardiomyopathy.
RA: right atrium
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concentrated at the fixed point of the descending thoracic 
aorta, at the level of the ligamentum arteriosum.101
Aortic injury most commonly results from transverse 
tears, and can be segmental or circumferential, and partial 
or transmural. Partial lacerations usually involve only the 
inner two wall layers, resulting in a contained rupture. The 
adventitia may be injured in up to 40% of cases and adven-
titial injury is almost universally fatal because of rapid 
exsanguination. Temporary tamponade may be achieved by 
surrounding mediastinal soft tissues.8,101
Recommendation for echocardiography in patients 
with suspected acute traumatic aortic injuries:
Recommended:
1. TOE is one of the first line imaging methods 
recommended for diagnostic confirmation in 
patients with suspected acute traumatic aortic 
injury. (In practice, in most trauma centres, 
rapid trauma CT protocols are used as the first 
line of imaging.)
2. TOE is also recommended intraoperatively to 
guide surgical and anaesthesic decisions.
Not recommended:
1. TOE is relatively contraindicated in patients 
with cervical spine fractures.
Acute traumatic cardiac injuries
In blunt cardiac trauma, several forces may be involved, 
including compression of the heart between the spine and 
sternum, abrupt pressure fluctuations in the chest and abdo-
men, shearing from rapid deceleration, and blast injury. In 
addition, fragments from rib fractures can directly trauma-
tize the heart. Unless the treating clinicians have experience 
in trauma, it is easy to underestimate the potential tissue 
damage in blunt trauma, in particular in blast injuries.
In patients with minor injuries and no tachycardia, hypo-
tension, respiratory difficulty, chest pain or other concern-
ing symptoms, no intervention besides clinical assessment 
may be needed. In patients with significant trauma, clinical 
assessment is difficult and often not sensitive or specific 
enough for detection of cardiac injury.102,103 Clinicians 
must assume that hypotension and tachycardia in the trauma 
patient results first from the haemorrhage, but the presence 
of hypotension and tachycardia in the setting of isolated 
chest trauma suggests that pericardial tamponade and/or 
tension PTX/haemothorax should be excluded. Here, the 
clinician should perform a standard bedside ultrasound 
examination (i.e. Focused Assessment with Sonography for 
Trauma (FAST)), which includes screening for clinically 
significant haemopericardium and pleural collection.16 
Once pericardial tamponade is excluded, a standard 
echocardiogram is useful in patients with signs of HF or 
abnormal heart sounds to diagnose the cause of dysfunc-
tion, estimate the need for volume resuscitation or inotropic 
support and identify other injuries (including RV dysfunc-
tion) requiring intervention or monitoring for arrhythmia. 
TOE is superior to TTE104 for investigating the cause of 
persistent haemodynamic instability or other problems 
potentially related to cardiac injury. TOE provides a clearer 
view of wall motion abnormalities and valvular (i.e. valvu-
lar tear) and septal (i.e. septal rupture) injuries. Blunt car-
diac injury includes a spectrum of pathology, ranging from 
clinically silent transient arrhythmias to deadly cardiac wall 
rupture.
Cardiac contusion/dysfunction. The most common expres-
sion of cardiac contusion is cardiac dysfunction (dimin-
ished contractility in the absence of arrhythmia or 
haemorrhage). The right heart is most commonly affected, 
due to its anterior position and ventricular injuries are as 
common as atrial injuries. Global dysfunction or abnormal 
regional wall motion may be seen. TAPSE should be 
always reported in the first echocardiographic protocol and 
used for follow-up of RV function, taking into account hae-
modynamics, ventilator, and inotropic and pressure sup-
port, as well as the arterial blood gases at the time of the 
study. Careful scanning of the RV free wall should be per-
formed, looking for thinned myocardial segments at risk of 
rupture. In the presence of pericardial collection there is a 
significant risk of RV free wall rupture and careful screen-
ing for a pseudoaneurysm should additionally be performed 
using all available acoustic windows. Paradoxical septal 
movement might be the result of a right bundle branch 
block (RBBB) and if the ECG confirms its presence, car-
diac contusion should be suspected.
Myocardial rupture. Myocardial rupture is the most seri-
ous type of blunt cardiac injury, where the majority of 
patients do not reach the emergency department alive. Of 
those who do, rapid diagnosis by echocardiography fol-
lowed by appropriate intervention can be lifesaving. Less 
severe injuries to the ventricular wall may lead to delayed 
necrosis and manifest as late rupture, several days post-
admission, and patients should be screened to determine 
those at risk.
Septal and valvular injury. Septal and valvular injury are both 
rare. Valvular injury occurs at the aortic>mitral>tricuspid 
valves. The lesion may consist of a tear of the leaflet, the 
papillary muscle and/or chordae tendineae with acute val-
vular regurgitation, clinically suspected and confirmed by 
echocardiography.
AMI. Although rare, AMI may result from coronary 
artery dissection, laceration and/or thrombosis. The left 
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anterior descending artery is the most frequently affected 
artery. An ECG and an echocardiogram should be obtained 
early in the case of suspected MI.
Arrhythmia. Arrhythmia raises the suspicion of cardiac 
trauma if haemorrhage is excluded, in particular if unex-
plained, persistent tachycardia, new bundle branch block 
and minor arrhythmia (i.e. occasional premature ventric-
ular contractions) occur, and it is an indication for rapid 
echocardiographic evaluation.
Recommendation for echocardiography in patients 
with suspected acute traumatic cardiac injuries:
Recommended:
1. Focused cardiac ultrasound examination 
should be immediately performed in patients 
with isolated chest trauma, hypotension and 
tachycardia to exclude pericardial tamponade 
or tension PTX.
2. Emergency echocardiographic examination is 
necessary in patients with isolated chest 
trauma, no cardiac tamponade or PTX but 
having persistent tachycardia or hypotension, 
signs of HF, abnormal auscultatory findings, 
abnormal ECG tracings or recurrent arrhyth-
mias. In such patients, echocardiography can 
help diagnose the cause of abnormal findings, 
estimate the need for volume resuscitation or 
inotropic support and identify other injuries 
requiring intervention.
3. TOE is superior to TTE in the assessment of 
traumatic cardiac injury.
Not recommended:
1. In patients with minor chest injuries and no 
tachycardia, hypotension, respiratory difficulty, 
chest pain or other concerning symptoms, no 
intervention besides clinical assessment may be 
needed.
Post-procedural complications
The indications and processes for intra-operative and intra-
procedural echocardiography are widely recognized and 
documented. Following cardiac surgery or any catheter 
laboratory intervention, if the patient presents with haemo-
dynamic instability and/or inadequate cardiac output, echo-
cardiography should be performed as a first step examination 
to identify the underlying diagnosis. A complete TTE 
examination should be performed, but frequently TOE will 
be preferred due to the poor quality of transthoracic acous-
tic windows, in particular immediately after cardiothoracic 
surgery.
Post-surgical complications
Pericardial collection and cardiac tamponade are common 
complications after cardiac surgery. Diagnosis is clinical; 
however, when echocardiography is required, if TTE is 
negative, TOE should be performed if there is diagnostic 
uncertainty prior to return to the theatre for surgical evacu-
ation. Frequently, echocardiographic features of tamponade 
will be absent, and pericardial collections are small and 
localized (and may be missed using TTE).
Myocardial function can be significantly impaired after 
a long bypass run and/or where cardioplegia has been chal-
lenging. Where there has been coronary intervention, there 
should be a high index of suspicion for coronary disruption, 
and a low threshold for coronary angiography. As the first 
2–4cm of the coronary arteries can be identified using TOE, 
any studies performed in this context should specifically 
image the coronary arteries, and where mitral valve surgery 
has been undertaken, specifically address the course of the 
circumflex coronary artery in the region of the posterior 
mitral valve (MV) annulus.
The RV is particularly susceptible to post-bypass 
dysfunction, the mechanisms of which are unclear. As RV 
dysfunction may seriously compromise the prognosis of the 
patient, RV size and function must be carefully checked in 
any cardiac post-operative patient. TAPSE is one of the 
parameters of RV function that is strongly recommended to 
be reported in the pre- and perioperative echocardiographic 
assessments – always taking into consideration the haemo-
dynamics and degree of respiratory and inotropic support. 
Because TAPSE diminishes immediately after cardiac sur-
gery it is recommended to measure TAPSE intra-opera-
tively (pre- and post-cardioplegia, after intervention, 
post-protamine administration and in certain circumstances, 
i.e. RV to PA conduit, post-chest-closure). When coronary 
artery manipulation has been part of the procedure it should 
not be assumed that the cause of RV dysfunction is solely 
cardioplegia related.
Echocardiography immediately after heart transplant is 
essential, particularly in haemodynamically unstable 
patients. It will allow ruling out early rejection, early RV 
dysfunction, tamponade or other causes of instability.
The details of echocardiographic diagnosis of post-car-
diac surgical complications are fundamental to periopera-
tive echocardiographers, warrant separate consideration 
and are described elsewhere. Similar considerations are 
given for heart transplant patients.
Post-catheter/electrophysiology laboratory 
complications
Acute complications relevant to the echocardiographer 
generally include tamponade, ventricular failure and car-
diogenic shock, occlusion of coronary stents and displace-
ment of implanted devices. The commonest of these are 
covered in the recommendations outlined in this 
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document.87 When intracardiac devices have been 
implanted, haemodynamic instability should prompt ini-
tially TTE imaging. However, this will usually be followed 
by an expert TOE study that should be reviewed with the 
implanting cardiologist. In addition to demonstration of 
device displacement, echocardiography should be used to 
determine the time, urgency and strategy for further 
intervention.
Extracorporeal support
Extracorporeal support is increasingly used to support 
critically ill patients with severe cardiac and/or respira-
tory failure. It may be used as a bridge to recovery, trans-
plantation, decision for further intervention, or in a very 
few patients with cardiac failure, as a destination therapy. 
Although echocardiography for extracorporeal support is 
highly specialized, certain key principles apply.105,106 
First, extracorporeal support is not a treatment per se, but 
rather a supportive therapy whilst awaiting resolution of 
the underlying pathological process. Thus echocardiogra-
phy has a vital role in excluding any potentially treatable 
underlying cause for cardiorespiratory failure. Second, 
echocardiography is essential to determine the require-
ment for the RV and/or LV support and level of support 
required, and in assessing the ability of the right and left 
ventricles to support the extracorporeal circuit. This 
demands that the practitioner understands the different 
types of circuit, and the load that each will place on the 
heart. Third, echocardiography is mandatory to exclude 
cardiovascular contraindications to initiation of support 
(Table 2). Echocardiography subsequently has a vital role 
in its successful implementation, including confirming/
guiding correct cannula placement, ensuring the goals of 
support are met, detecting complications and assessing 
tolerance to assistance. Finally, in patients requiring extra-
corporeal cardiac support, various echocardiographic 
parameters have been proposed to be used in conjunction 
with clinical and haemodynamic assessment in order to 
attempt to predict those patients who can be successfully 
weaned. Any practitioner intending to undertake echocar-
diography in patients on or requiring extracorporeal sup-
port should undergo specialized training in the techniques 
and their application.
Conclusions
Echocardiography has become the primary imaging tool for 
bedside diagnosis and monitoring of patients in acute car-
diovascular conditions. It is non-invasive, provides rapid 
and accurate assessment of cardiac morphology and haemo-
dynamics under stressful situations and is very useful in 
assisting therapeutic procedures. The fact that echocardiog-
raphy can be repeated when required makes it highly useful 
in emergency/critical care circumstances.
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